Gaurav K. Shah, MD

Dr. Shah sees Patients in the Following Location

Curriculum Vitae

Work Address
West Coast Retina Medical Group
1445 Bush Street
San Francisco, CA 94109

Education Post Doctoral Training Licensure and Board Certification Memberships, Offices and Committee Appointments Awards and Honors Scientific Journal reviewer
Research
The Retina Institute and Washington Univrsity Wills Eye Hospital, Retina Service, July 1997-1999
University of Minnesota, July 1995-June, 1997
St. Paul Ramsey Medical Center/Phillips Eye Institute
University of Illinois Eye and Ear Infirmary. Laboratory of Retinal Circulation and Metabolism, Jan, 1990-Oct, 1991

Bibliography

Book Chapters
  1. Yuan, Sean, BS, Vishal Parikh, MD, Gaurav K. Shah, MD, Chapter 7: Sutureless Small-Gauge Vitrectomy, Journal of VitreoRetinal Diseases, Volume 4, Issue 6, November /December 2020
  2. Vangipuram G, Shah GK. (2020) ‘Chapter 13: Future Direction in Diabetic Eye Disease’, in Lazzaro, D. (ed.) Diabetes and the Eye: Latest Concepts and Practices. Bentham Science, In Press.
  3. Parikh VS, Rao R, Shah GK. Rhegmatogenous Retinal Detachment. In: Yanoff M, Duker JS. Ophthalmology, 5th Edition. Elsevier Health Sciences; 2018
  4. Parikh VS, Shah A, Shah GK. Retinal Tears and Holes. In: Retina Illustrated, ed. Ehlers JP. Submitted 2018
  5. Connors, DB, Shah, GK When should I refer a patient with an epiretinal membrane and what if there is associated cystoid macular edema? Curbside Consultation in Retina: 49 Clinical Questions Chapter 27: 2016
  6. Shieh, W, Shah, GK Future Direction in DME/DR Diabetes: Current and Future Development Vol 2 Chapter 11 2016
  7. Ahmad, BU, Shah, GK, Engelbrecht, NE, Thomas, MA, Smith, BT Retinal Detachment Repair: Scleral Buckling Procedures Expert Techniques in Ophthalmic Surgery: Chapter 24
  8. Rao RC, Shah GK Rhegmatogenous Retinal Detachment Ophthalmology 4th Edition Chapter 6.3
  9. Jonisch J, Shah GK. Diagnosis of AMD. In: Regillo CD, Ho AC. Age-Related Macular Degeneration: Diagnosis and Treatment. Philadelphia: Springer. Published.
  10. Shah GK: When Should I Refer A Patient with an Epiretinal Membrane and What if there is Associated Cystoid Macular Edema. Fekrat S, editor, Curbside Consultation in Retina: 49 Clinical Questions, Thorofare, 2010. Slack Incorporated.
  11. Shah GK, Brown GC: Use of fluorescein angiography, fundus photography and ultrasound in diabetic retinopathy. Ophthalmology Monographs. American Academy of Ophthalmology.
  12. Shah GK, Shields JS, Shields CL, Brown GC: Ocular Tumors. In Mercado HQ, Liggett P, Alfaro V, DeJuan E, and Tano Y, editors, Macular Surgery, Philadelphia, 2000. JB Lippincott Williams & Wilkins, 336-344.
  13. Shah GK, Krachmer JK: Infectious diseases: Corneal manifestations. In Krachmer JH, Mannis MJ, and Holland EJ, editors, Cornea, 2nd Edition St. Louis, 1997. Mosby, 1003-1016.
  14. Samuelson TW, Shah GK: Pseudoexfoliative glaucoma. In Sherwood M, editor, Ophthalmology, St. Louis, 1998, Mosby. Section 12, Chapter 14, 14.1-14.4.
  15. Shah GK, Krachmer JK: Infectious diseases: Corneal manifestations. In Krachmer JH, Mannis MJ, and Holland EJ, editors, Cornea, 3rd Edition St. Louis, 2004. Mosby, In print
  16. Ramaiya K, Shah GK. Central Retinal Vein Occlusion. The Wills Eye Institute Five-Minute Ophthalmology Consult. Submitted/In Press.
  17. Ramaiya K, Shah GK. Branch Retinal Vein Occlusion. The Wills Eye Institute Five-Minute Ophthalmology Consult. Submitted/In Press.
  18. Ramaiya K, Shah GK. Choroidal Folds. The Wills Eye Institute Five-Minute Ophthalmology Consult. Submitted/In Press.
Original Reports
  1. Gautam Vangipuram, Kevin J. Blinder, Sabin Dang, Gaurav K. Shah, Response to: Workup following retinal artery occlusion- experience from an outpatient retina clinic and the delay in workup, Graefe’s Archive for Clinical and Experimental Ophthalmology, 2021 Nov.11; 1-2.
  2. Matthew R. Starr, Anthony Obeid, Xinxiao Gao, Edwin H. Ryan, Gaurav K. Shah, Claire Ryan, Malika L. Madhava, Sean M. Maloney, Adam Z. Adika, Krishi V. Peddada, Kareem Sioufi, Michael Ammar, Luv G. Patel, Nora J. Forbes, Antonio Capone Jr., Geoffrey G. Emerson,Geoffrey,Daniel P. Joseph, Dean Eliott, Carl D. Regillo, Jason Hsu, Omesh P. Gupta, Yoshihiro Yonekawa Prophylactic internal limiting membrane peeling during rhegmatogenous retinal detachment surgery, Wiley Online Library, ACTA Ophthalmologica, June 26, 2021.
  3. Gautam Vanipuram,, Louise Yang, M. Parker Weigel, Barton L. Blackorby, Kevin J Blinder, Sabin Dang, Gaurav K. Shah, MD, Workup following retinal artery occlusion- experience from ans outpatient retina clinic and delay in workup. Gaefe’s Archive for Clinical and Experimental Ophthalmology March 12, 2021.
  4. Waseem H Ansari, MD, Barton L. Blackorby, MD, Gaurav K. Shah, MD, Kevin J. Blinder. MD, Sabin Dang, MD, OCT Assistance in Identifying Retinal Breaks in Symptomatic Posterior Vitreous Detachments, Ophthalmic Surgery, Lasers and Imaging Retina, November 2020, Vol.51, No.11
  5. David Xu, MD, Peter J. Berlin, MD, Patrick C. Staropoli, MD, Nicolas A. Yannuzzi, MD, Gautam Vangipuram, MD, Allen Chiang, MD, Gaurav K. Shah, MD, Justin H. Townsend, MD, Edwin H. Ryan, MD, Michael A. Klufas, MD, Clinical Outcomes in Sequential, Bilateral Rhegmstogenous Retinal Detachment: A Multicenter, Paired- Eye Analysis, Ophthalmology Retina, November 2020
  6. James H. Garcia, Mark Johnson, Gaurav Shah, Carsten H. Meyer, Gustavo B. Melo, Eduardo B. Rodrigues, Macular microhole and foveal red spot syndrome: a critical review of literature, Graefe’s Archive for Clinical and Experimental Ophthalmology, 23 October 2020
  7. Matthew R. Star, Anthony Obeid, Xinxiao Gao, Edwin H. Ryan, Gaurav K Shah, Clair Ryan Malka L. Madhava, Sean M. Maloney, Adam Z. Adika, Krishi V Peddada, Kareem Sioufi, Michael Ammar, Luv G. Patel, Nora J. Forbes, Antonio Capone Jr., Geoffrey G. Emerson, Daniel P. Joseph, Dean Eliott, Carl D. Regillo, Jason Hsu, Omesh P. Gupta, Yoshihiro Yonekawa, For the Primary Detachment Outcomes (PRO) Study Group Prophylactic internal limiting membrane peeling during rhegmatogenous retinal detachment surgery Acta Ophthalmological August 4, 2020
  8. Alexander R Bottini, MD, Barton L. Blackorby, MD, Madelyn Michaels BA, Katherine Burkett, BA, Sabin Dang, MD, Kevin J. Blinder, MD, and Gaurav K. Shah, MD Long-term Outcomes in Macular Telangiectasia Type 2 With Subretinal Neovascularization Science Digest Ophthalmology Volume 127, Issue 8, August , 2020 pages 1077-1085
  9. Alexander R. Bottini, MD, Barton L. Blackorby, MD, Madelyn Michaels, BA, Katherine Burkett, BA, Sabin Dang, MD, Kevin J. Blinder MD, Gaurav K. Shah, MD, Long-term Outcomes in Macular Telangiectasia Type 2 with Subretinal Neovascularization Sage Journals. June 17, 2020
  10. Daniel P. Joseph, MD. PhD., Edwin H. Ryan, MD, Claire M. Ryan, BA, Nora J Forbes, MS, Sushant, Wagley, MD, Yoshihiro Yonekawa, MD, Robert A. Mittra, MD, D. Wilkin Parke, MD, Geoffrey G. Emerson, Gaurav K. Shah, MD, Kevin J. Blinder. MD, Anotonio Capone,MD, George A. Williams, Dean Eliott, MD, Omesh P. Gupta, MD, Jason Hsu, MD, Carl D. Regillo, MD, Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Primary Retinal Detachment Outcomes Study Report Number 3, American Academy of Ophthalmology, May 5, 2020
  11. Edwin H. Ryan, MD, Claire M. Ryan, BA, Nora J Forbes, MS, Yoshihiro Yonekawa, MD, Sushant, Wagley, MD, Robert A. Mittra, MD, D. Wilkin Parke, MD, Daniel P. Joseph, MD, Geoffrey G. Emerson, Gaurav K. Shah, MD, Kevin J. Blinder. MD, Anotonio Capone,MD, George A. Williams, Dean Eliott, MD, Omesh P. Gupta, MD, Jason Hsu, MD, Carl D. Regillo, MD, Primary Retinal Detachment Outcomes Study Report Number 2: Phakic Retinal Detachment Outcomes, American Academy of Ophthalmology, March 9, 2020
  12. Barton L. Blackorby, MD, Kevin Broderick MD, Peter Berlin, MD, Daniel M. Berinstein, MD, Brice Hwang MD Justin Shortell MD D. William Parke lll MD Sabin Dang MD, Kevin J. Blinder, MD Gaurav K. Shah MD, Analysis of Emergent Nonhospital-Associated Retina Practice, March 20, 2020
  13. Barton L. Blackorby, MD, Abdallah M. Jeroudi, MD, Kevin J. Blinder, MD, Gaurav K. Shah, MD, Epiretinal Membrane Formation after Treatment of Retinal Breaks: Cryoretinopexy versus Laser Retinopexy. Ophthalmology Retina 2019 Dec (12): 1087-1090
  14. Yicheng Chen, MD1,2, Gaurav K. Shah, MD1 , Vaishali Shah1 , Kevin J. Blinder, MD1 , Abdallah M. Jeroudi, MD1 , Anthony Leonard, MD, PhD3,4 , Marina Gilca, MD5 , John S. Pollack, MD5 , Rui Wang6 , Charles C. Wykoff, MD, PhD6 , Brett M. Weinstock, MD7 , Carl D. Regillo, MD, FACS7 , Tave van Zyl, MD8 , Bobeck S. Modjtahedi, MD8 , Dean Eliott, MD8 , Ananda Kalevar, MD, FRCS(C)9 , J. Michael Jumper, MD , Ryan J. Whitted, MD10, Gregory Lee, MD10, John W. Kitchens, MD10, Anthony Joseph, MD11, Jeffrey S. Heier, MD11, Mahdi Rostamizadeh, MD12, Musa Abdelaziz, MD12, Lawrence J. Singerman, MD, FACS12, Jonathan K. Hu, MD13, and Asheesh Tewari, MD13,14, Outcomes and Practice Preferences After Endophthalmitis Following Anti-VEGF Intravitreal Injection, Journal of VitreoRetinal Diseases 2019, Vol. 3(6) 411-419
  15. Michael F. Marmor, MD William F. Mieler, MD David Sarraf,MD, and Gaurav K. Shah, MD, Drug Toxicity to the Retina and Optic Nerve: Are You Missing It?, EyeNet Magazine, Clinical Clinical Update, September 2019, 33-36
  16. Himanshu K. Banda, MD, Gaurav K. Shah, MD, Kevin J. Blinder, MD, Applications of fundus autofluorescence and widefield angiography in clinical practice, Canadian Journal of Ophthalmology, Vol. 54 Issue 1 Feb. 2019, 11-19
  17. Banda H, Shah GK.“Application of Wide-field infrared imaging in Retinoschisis, Retinal Detachment, and Schisis Detachments.” Journal of Vitreoretinal Disease, in press.
  18. Rajesh C. Rao, Gaurav K. Shah. Internal Limiting Membrane Peeling in Macula-off Retinal Detachment Complicated by Grade B Proliferative Vitreoretinopathy. American Journal of Ophthalmology, Vol. 196 Dec. 2018, 212-13
  19. Banda H, Shah GK, Blinder KJ. “Applications of Fundus Autoflourescence and Wide-field Angiography in Clinical Practice.” Review article. Accepted by the Canadian Journal of Ophthalmology, in press.
  20. Banda H, Dang S, Shah A, Shah G. “Bilateral Solar Retinopathy After Gazing at The Great American Eclipse.” Journal of Vitretoreitnal Diseases. July 31 2018.
  21. Parikh VS, Dang S, Shah GK. Role of OCT Angiography in Neovascular AMD. Retinal Physician. 2018:15; 29-31
  22. Blackorby, B; Shah, A; Shah, G. (2018). Comparison of Anti-VEGF Therapy for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions. Intravitreal Injections. Vol 7, Issue 2. 16-23
  23. Abdallah M. Jeroudi, MD, Wen-Shi Shieh, MD, Yicheng Chen, MD, Daniel B. Connors, MD, Kevin J. Blinder, MD, and Gaurav K. Shah, MD. Topical Anesthesia in 27-Gauge Pars Plana Vitrectomy Journal of VitreoRetinal Diseases Vol. 2:2 March/April 2018
  24. Daniel Connors, MD, Gaurav Shah, MD, Kevin Blinder, MD, and Sabin Dang, MD. Early Versus Delayed Vitrectomy for Nondiabetic Vitreous Hemorrhage Journal of VitreoRetinal Diseases Vol. 2:2 March/April 2018
  25. Chen, Y, Shah, GK. Outcomes and Practice Preferences After Endophthalmitis Following Anti-VEGF Intravitreal Injection (the “Work”) RETINA The Journal of Retinal and Vitreous Diseases. March, 2018
  26. Shah, GK, Hardten, DR, Pecen, P, Moshfeghi, A, Devgan, U, Patterson, LE. Considerations for Cataract Surgery in Diabetic Patients: Collaboration among specialties enhances outcomes. Retinal Physician March, 2018
  27. Jeroudi, A, Shieh, W, Chen,Y, Connors, D, Blinder, KJ, Shah, GK Topical Anesthesia in 27-Gauge Pars Plana Vitrectomy SAGE journals: Journal of VitreoRetinal Diseases February 26, 2018
  28. Dang, S, Shah, GK, Parikh, VS, Role of OCT Angiography in Neovascular AMD: Benefits in diagnosis and clinic workflow Retinal Physician January-February 2018
  29. Banda, H, Shah, GK Innovations in Vitreoretinal Surgery: Novel Viewing Technology in Surgeon Education Vitreo Retinal Society – India December, 2017
  30. Shieh, W, Shah, GK, Blinder KJ, "Coats’ disease-related macular edema treated with combined aflibercept and laser photocoagulation " Case Reports in Ophthalmological Medicine 2017;2017:2824874
  31. Shah, GK, R Singh, CC Wykoff, DRIL a Robust Biomarker for DME EyeNet Magazine November 2017
  32. Chen, Y, Shah, V, Jeroudi, AM, Blinder, KB, Shah, GK Surgical Detachment of the Anterior Hyaloid Membrane From the Posterior Lens Capsule Journal of VitreoRetinal Diseases April 2017 1(4)1-4
  33. Ho_V, Shah_GK Short- and Long- Term Outcomes of Vitreoretinal Surgeries with Deferred First Postoperative Visits at Day 3 or Later Journal of VitreoRetinal Diseases January 2017 1(2): 126-132
  34. Chinskey, ND, Shah, GK Epiretinal Membrane Peeling in Patients With Good Preoperative Vision Journal of VitreoRetinal Diseases January 2017 1(1): 52 - 56
  35. Jeroudi, AM, Shah, V, Blinder, KB, Shah,_GK Management of degenerative Retinoschisis associated retinal detachment Ophthalmology Retina July/August 2017 1(4):266-271
  36. Ho, VY, Shah, V, Yates, DM, Shah, GK GoPro HERO 4 Black Recording of Scleral Buckle Placement during Retinal Detachment Repair Canadian Journal of Ophthalmology 2017 52(4)416-418
  37. Mshfeghi, DM, Shah, GK 8 Questions with Dr. Moshfeghi OSLI 2016 September 47(9): 886-888
  38. Ho,VY, Shah, GK Wide-Field Infrared Imaging: A Descriptive Review of Characteristics of Retinoschisis, Retinal Detachment, and Schisis Detachments Retina 2016 August;36(8): 1439 -1445
  39. Chinskey, ND, Shah, GK Practical Update to Epiretinal Membranes OSLI July 2016 Vol 47, Number 7, Page(s) 614-616
  40. Walia, HS, Shah GK, Blinder, KJ Treatment of CNV Secondary to Presumed Ocular Histoplasmosis with Intravitreal Aflibercept 2.0 mg Injection Can J Ophthalmology April 2016 Vol 51(2): 91-96
  41. Ho,V, Shah, GK, Liu, EM ReSure Sealant for Pars Plana Vitrectomy Wound Closure OSLI 2015 November – December; 46(10): 1042-4
  42. Chinskey, ND, Shah, GK Getting Familiar with EVA Early experiences with a high-speed vitrectomy system is promising Retina Today September 2015; Vol 10 No 6: 73-75
  43. Rajagopal, R, Shah, GK, Blinder, KJ, Altaweel, MA, Eliott, D, Wee, R, Cooper, B, Walia, H, Smith, BT, Joseph, DP Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study Ophthalmic Surgery, Lasers and Imaging Retina September 2015 - Volume 46 · Issue 8: 844-850
  44. Rao, R, Shah, GK Letter to the Editor: "Effect of internal limiting membrane peeling on the development of epiretinal membrane after pars plana vitrectomy for primary Rhegmatogenous retinal detachment Retina May 2015; 35(5):880-885
  45. Ahmad, BU, Blinder, KJ, Meyer, JC, Shah GK, Laser Therapy versus Observation for Symptomatic Retinal Artery Macroaneurysms Graefe’s Archive of Clinical and Experimental Ophthalmology April 2015 Vol 253, Issue 4 pp 537-541
  46. Meyer, JC, Shah, GK, Blinder, KJ, Waheed, NK, Reichel E, Stalmans, P, Singer, M. Tewari, A Early evolution of the Vitreomacular Interface and Clinical Efficacy after Ocriplasmin Injection for Symptomatic Vitreomacular Adhesion OSLI February 2015 46(2):209-216
  47. Mansour, AM, Arevalo, JF, Badal, J, Moorthy, RS, Shah_GK, Zeqarra, H, Pulido, JS, Charbaji, A, Amselem, L, Lavaque, AJ, Casella, A, Ahmad, B, Paschall, JG, Caimi, A, Staurenghi, G Paraproteinemic Maculopathy Ophthalmology Vol 121(10) Oct 2014 Pgs 1925-1932
  48. Franklin AJ, Shah GK, Walia HS. Minimally Invasive Vitrectomy Surgery Using Small-gauge Instrumentation Retinal Physicians, Vol (11) Sept 2014 pgs: 45-50
  49. Franklin AJ, Shah GK, Walia HS. Minimally Invasive Vitrectomy Surgery Using Small-gauge Instrumentation Retinal Physicians, Vol (11) Sept 2014 pgs: 45-50
  50. Ahmad B, Shah GK Presbyopia-Correcting Intraocular Lenses and Corneal Refractive Procedures: A Review for Retinal Surgeons Retina 2014 June, 34 (6): 1046-1054
  51. Hariprasad SM, Walia, HS, Shah GK ILM peeling a vital intervention for many vitreoretinal disorders Ophthalmic Surgery, Lasers & Imaging Retina March/April 2014 Vol. 45(2): 92-96
  52. Rao RC, Shah GK A Glimpse into Epigenetic Regulation of Age-Related Macular Degeneration Ophthalmology Management December 2013, Issue 64
  53. Patel, M, Shah GK, Davies, JB, Mittra, RA, Eliott, D Re-evaluation Our Perspective on Retinal Artery Occlusion from Carotid Dissection: A Report of Three Cases and Review of the Literature Ophthalmic Surgery, Lasers & Imaging Retina Nov/Dec 2013 Vol 44, No. 6 Pg 1-6
  54. Meyer, JC, Shah GK Retrospective Analysis of Laser Therapy Versus Observation for Symptomatic Retinal Artery Macroaneurysms Investigative Ophthalmology & Visual Sciences June 2013 Vol 54, 5771
  55. Blinder KJ, Rao RC, Shah_GK, Smith BT Internal Limiting Membrane Peeling for Primary Rhegmatogenous Retinal Detachment Repair Ophthalmology, May 2013:120(5): 1102
  56. Aschbrenner M, Jonisch J, Lee A, Shah GK. Surgical Numbers of Vitreoretinal Fellows in Training Programs in North America. In Print
  57. Almony A, Nudleman E, Shah GK, Blinder KJ, Eliott DB, Mittra Ra, Tewari A. Techniques, Rationale and Outcomes of Internal Limiting Membrane Peeling. Retina 2012; 32(5):877-891.
  58. Bowen BE, Manning RA, Foster JB, Kurup SK, Ramaiya KJ, Shah GK. Diagnostic and Therapeutic Challenges. Retina 2011; 31(9):1967-71.
  59. Almony A, Mansouri A, Shah GK, Blinder KJ. Efficacy of Intravitreal Bevacizumab after Unresponsive Treatment with Intravitreal Ranibizumab. Can J Ophthalmology 2011 April 24, 2009; 46(2):182-185.
  60. Almony A, Dhalla MS, Shah GK. Macular Ocular Coherence Tomography Findings May Guide Treatment in Retinal Arterial Macroaneurysms. Ophthalmic Surgery, Lasers & Imaging May 2010; 41(3):1-2.
  61. Shah GK, Hughes MS. Clinical Model of Exudative AMD. Letter to the Editor. Retina 2010; 30:380-381.
  62. Mehta S, Blinder KJ, Rybak MC, Shah GK, Grand MG. Pars Plana Vitrectomy Versus Combined Pars Plana Vitrectomy and Scleral Buckle for Primary Repair of Rhegmatogenous Retinal Detachment. Can J Ophthalmology 2011 June; 46(3):237-41.
  63. Mehta S, Blinder KJ, Shah GK, Kymes, SM, Schlief S, Grand MG. Intravitreal Bevacizumab for the Treatment of Refractory Diabetic Macular edema. Ophthalmic Surgery Lasers and Imaging 2010; 41(3):323-329.
  64. Mansouri A, Almony A, Shah GK, Blinder KB, Sharma S. Recurrent Retinal Detachment: Does Initial Treatment Matter? Br J Ophthalmology 2010; 94(10):1344-1347.
  65. Sheybani A, Almony A, Blinder KJ, Shah GK. Neovascular Age-Related Macular Degeneration and Anti-VEGF Non-responders. Expert Review of Ophthalmology. 2010; 5:35-41.
  66. Almony A, Blinder KJ, Harocopos GJ, Shah GK, Rao PK, Smith ME, Dintzis SM, Van Gelder RN. Histologic and Immunohistochemical Features of an Epiretinal Membrane Overlying a Combined Hamartoma of the Retina and Retinal Pigment Epithelium. Retinal Cases & Brief Reports 2010; 4:184-186.
  67. Dayani PN, Blinder KJ, Shah GK, Holekamp NM, Joseph DP, Wilson B, Thomas MA, Grand MG. Surgical Outcome of Scleral Buckle Compared with Scleral Buckle with Vitrectomy for Treatment of Macula-off Retinal Detachment. Ophthalmic Surgery Lasers and Imaging 2009; 40(6):539-47.6
  68. Rao PK, Almony A, Shah GK, Cooper BA, Smith ME. Histologic and Immunohistochemical Features of a Vitreous Cyst. Retinal Cases & Brief Reports 2009; 3:60-61.
  69. Schadlu R, Shah GK. Early Postoperative Intraocular Pressure After 23 Gauge Sutureless Small Incision Pars Plana Vitrectomy. Retina 2009; 29:1043-1044.
  70. Rao PK, Almony A, Shah GK, Cooper BA, Smith ME. Histologic and Immunohistochemical Features of a Vitreous Cyst. Retinal Cases & Brief Reports 2009; 3:60-61.
  71. Shah GK, Sang DN, Hughes MS.Verteporfin Combination Regimens in the Treatment of Neovascular Age-Related Macular Degeneration. Retina 2009; 29:133-148.
  72. Schadlu, R., Shah, G.K., Prasad, A.G. Optical Coherence Tomography findings in Autosomal Macular Dystrophy Ophthalmic Surgery Lasers and Imaging Volume 39, Issues 1, Year 2008 pp. 69-72
  73. Tewari A, Almony A, Shah GK. Macular Hole Closure with Triamcinolone-Assisted Internal Limiting Membrane Peeling. Retina 2008; 28:1276-1279.
  74. Fintak D, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma, S. Incidence of Endophthalmitis Related to Intravitreal Injection of Bevacizumab and Ranibizumab. Retina 2008; 28:1395-1399.
  75. Schadlu R, Tehrani S, Shah GK, Prasad AG. Long-Term Follow-up Results of ILM Peeling During Vitrectomy Surgery for Premacular Fibrosis. Retina 2008; 28:853-857.
  76. Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra R Intravitreal Bevacizumab Combined with Verteporfin Photodynamic Therapy for Choroidal Neovascularization in Age-Related Macular Degeneration. Retina 2008; 28:675-681.
  77. Schadlu R, Blinder KB, Shah GK, Holekamp NM, Thomas MA, Grand MG, Engelbrecht NE, Apte RA, Joseph DP, Prasad AG, Smith BT, Sheybani A. Intravitreal Bevacizumab for Choroidal Neovascularization in Ocular Histoplasmosis. Am J Ophthalmology 2008; 145:875-878
  78. Tewari A, Shah GK. Presbyopia Correcting Intraocular Lenses: What Retinal Surgeons Should Know. Retina 2008; 28:535-537
  79. Vemulakonda GA, Hariprasad SM, Mieler WF, Pince RA, Shah GK, Van Gelder RN. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmology 2008; 126:18-22.
  80. Tewari A, Shah GK, Fang A. Visual Outcomes with 23-Gauge Transconjunctival Sutureless Vitrectomy. Retina 2008; 28:258-262.
  81. Schadlu R, Shah GK, Prasad AG. OCT Findings in Autosomal Dominant Macular Dystrophy. Ophthalmic Lasers, Surgery & Imaging 2008; 39:69-72.
  82. Almony A, Dhalla MS, Feiner L, Shah GK. Macular Optic Coherence Tomography Findings in Progressive Outer Retinal Necrosis. Can J Ophthalmology 2007; 42:881.
  83. Shah GK. Intravitreal Anti-VEGF Plus PDT Combination Therapy for Neovascular AMD: A Clinical Perspective. Ophthalmology Management. AMD Update 2007; Issue 14.
  84. Smith BT, Shah GK. Combination Therapy for AMD-Related CNV. Review of Ophthalmology 2007 (October): 73-77.
  85. Dhalla MS, Blinder KJ, Shah GK, Feiner L, Tewari A. Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Idiopathic Juxtafoveal Telangiectasia Type 2A. Retinal Cases & Brief Reports, 2007 July-August; 27(6):804-5
  86. Tewari A, Dhalla MS, Shah GK. Surface Anesthesia for Office Based Retinal Procedures. Retina 2007; 27:804-805.
  87. Shah GK, Tewari A, Scott IU. 23-Gauge Vitrectomy. Retina Times 20:33-35, 2007.
  88. Tewari A, Shah GK, Dhalla MS, Shepherd JB. Combination Photodynamic Therapy and Juxtascleral Triamcinolone Acetonide for the Treatment of a Peripapillary Choroidal Neovascular Membrane. Br J Ophthalmology. 90(10):1323-4, 2006.
  89. Dhalla MS, Shah GK, Blinder KJ, et al. Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration. Retina 26(9):988-93, 2006.
  90. Wickens JC, Shah GK. Outcomes of Macular Hole Surgery and Shortened Prone Positioning. Retina. 26:902-904, 2006.
  91. Shah GK, Bovino JA, Harbour JW, Heier, J, et al. What is the Future for Academic Retina Programs? Part 1. Retina Times 2006 18:22-27
  92. Shah GK, Bovino JA, Harbour JW, Heier, J, et al. What is the Future for Academic Retina Programs? Part 2. Retina Times 2006 19:34-39
  93. Tewari A, Shah GK. Recent Advances in Vitrectomy Surgery. Review of Ophthalmology 2016 13(12):3-6
  94. Tewari A, Shah GK. Cataract Complications: The Retinal Perspective. Review of Ophthalmology 2006 13(8):57-62
  95. Tewari A, Shah GK. 23 Gauge: The Further Evolution of Vitrectomy. Review of Ophthalmology 2006 13(8):76-78
  96. Prasad A, Shah GK. Intravitreal Triamcinolone for Ischemic Branch Retinal Vein Occlusion with Serous Retinal Detachment. Retina 26:234-6, 2006.
  97. Tewari A, Shah GK. Recent Advances in Vitrectomy Surgery. Review of Ophthalmology 13(4):3-6, 2006.
  98. Chaum E, Fawzi A, Chang TS, Shah GK. Discussion of case report by Chaum. Diagnostic and Therapeutic Challenges. Retina 26:219-22, 2006.
  99. Hariprasad SM, Shah GK, Blinder KJ. Short-Term Intraocular Pressure Trends Following Intravitreal Pegaptanib Injection. American Journal of Ophthalmology 141:200-201, 2006.
  100. Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M. Triamcinolone-Assisted Internal Limiting Membrane Peeling. Retina 25:972-975, 2005.
  101. Hariprasad SM, Shah GK, Chi J, Prince RA. Determination of Aqueous and Vitreous Concentration of Moxifloxacin 0.5% After Delivery Via a Dissolvable Corneal Collagen Shield Device. Journal of Cataract & Refractive Surgery. 31:2142-2146, 2005.
  102. Council, MD, Shah GK, Lee HC, Sharma S. Visual Outcomes and Complications of Epiretinal Membrane Removal Secondary to Rhegmatogenous Retinal Detachment. Ophthalmology 112:1218-1222, 2005.
  103. Hariprasad SM, Prasad A, Smith M, Shah GK, Grand MG, Shepherd JB, Wickens J, Apte RS, Kiao RS, Van Gelder R. Clinicopathologic Report: Bilateral Choroiditis from Prototheca wickerhamii Algaemia. Archives of Ophthalmology 123:1138-1141, 2005.
  104. Lee H, Shah GK. Intravitreal Triamcinolone as Primary Treatment for Cystoid Macular Edema Secondary to Branch Retinal Vein Occlusion. Retina 25:551-555, 2005.
  105. Blinder KJ, Shah GK, Thomas MA, Holekamp NM, Joseph DP, Grand MG, Sharma S. Surgical Removal of Peripapillary Choroidal Neovascularization Associated with Age-Related Macular Degeneration. Ophthalmic Surgery and Laser; 36(3):358-364, 2005.
  106. Hariprasad SM, Shah GK. Treatment of Juxtafoveal Choroidal Neovascularization with Photodynamic Therapy Using Verteporfin in Eyes with Age-Related Macular Degeneration. Ophthalmic Surgery and Laser; 36(3):258-260, 2005.
  107. Hariprasad SM, Shah GK. Alternatives and Advances in Adjuvant Use for Vitreoretinal Surgery: A Focus on Triamcinolone Acetonide-Assisted Internal Limiting Membrane Peeling. Rev Ophthalmology 2005; Vol 12.
  108. Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars Plana Vitrectomy with Internal Limiting Membranectomy for Refractory Diabetic Macular Edema without a Taut Posterior Hyaloid. Graefe’s Archive for Clinical and Experimental Ophthalmology. 243:20-25, 2005.
  109. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA. Penetration Pharmacokinetics of Topically Administered 0.5% moxifloxacin Ophthalmic Solution in Human Aqueous and Vitreous. Archives of Ophthalmology. 123(1):39-44, 2005.
  110. Shah GK, Blinder KJ, Hariprasad SM, Thomas MA, Ryan EH, Bakal J, Sharma S. Photodynamic Therapy for Juxtafoveal Choroidal Neovascularization Due to Ocular Histoplasmosis Syndrome. Retina. 25(1): 26-32, 2005.
  111. Rosenblatt B, Shah GK, Blinder KJ. Photodynamic Therapy with Verteporfin for Peripapillary Choroidal Neovascularization. Retina. 25(1): 33-37, 2005.
  112. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills M, Grand MG. Management of Endogenous Fungal Endophthalmitis with Voriconazole and Caspofungin. American Journal of Ophthalmology. 139(1):135:40, 2005.
  113. Cooper BA, Blinder KJ, Shah GK, Foster W, Leibole M. Femtosecond Laser-Induced Premacular Hemorrhage. Retina. 24(5): 812-14, 2004.
  114. Rosenblatt BJ, Shah GK. Cystic Retinal Changes Demonstrated by Optical Coherence Tomography in Best Disease: Brief Report. Retina. 24(2):322-324, 2004.
  115. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Grand MG, Thomas MA, Holekamp NM, Mieler WF, Prince RA. Determination of Vitreous and Aqueous Concentration of Topically Administered Moxifloxacin 0.5% in Humans. Investigative Ophthalmology & Visual Science 45:S525, 2004.
  116. Shah GK, Hariprasad SM, Breit S, Mieler WF, Grand MG, Van Gelder RN. Treatment of Endogenous Fungal Endophthalmitis with Systemic and Intravitreal Voriconazole: A Clinical and Penetration Pharmacokinetic Study. Investigative Ophthalmology & Visual Science 45: S4011, 2004
  117. Sheidow T, Blinder KJ, Shah GK. Outcome Results in Macular Hole Surgery: An Evaluation of Internal Limiting Membrane Peeling with and without Indocyanine Green. (Letter to the Editor) Ophthalmology. 111(7):434, 2004.
  118. Cooper BA, Shah GK, Sheidow TG, Blinder KJ, Grand MG. Outcome of Macular Hole Surgery in Diabetic Patients with Nonproliferative Retinopathy. Retina. 24(3):360-2, 2004.
  119. Cooper BA, Shah GK, Grand MG, Bakal J, Sharma S. Visual Outcomes and Complications Following Multiple Vitrectomies for Diabetic Vitreous Hemorrhage. Retina. 24(1):19-22, 2004.
  120. Cooper BA, Blinder KJ, Shah GK, Boniuk I. Intruding Scleral Sutures Twelve Years After Primary Repair. Archives of Ophthalmology 122:1238, 2004
  121. Shah GK, Rosenblatt BJ, Smith M. Internal Limiting Membrane Peeling Using Triamcinolone Acetonide: Histopathologic Confirmation. American Journal of Ophthalmology. 138(4):656-7, 2004
  122. Shah GK, Cooper BA, Grand MG. Purtscher’s-Like Retinopathy in a Patient with Systemic Lupus Erythematosus. Ophthalmic Surgery, Lasers & Imaging. 35(5)438-9, 2004.
  123. Hariprasad SM, Mieler WF, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA: Human Intraocular Penetration Pharmacokinetics of Moxifloxacin 0.5% via Topical and Collagen Shield Routes of Administration. Transactions of the American Ophthalmological Society 102: 2004.
  124. Shah GK, Cooper BA, Grand MG, Hart WM. Acute Macular Neuroretinopathy and Associated Disc Swelling and Blind Spot Enlargement – Case Report. Canadian Journal of Ophthalmology. 38(7):602-04, 2003.
  125. Shah GK. Photodynamic Therapy for Choroidal Neovascularization After Thermal Laser Photocoagulation for Diabetic Macular Edema. American Journal of Ophthalmology 135(1):114-16, 2003.
  126. Shah GK, Vander JF. Letter to the Editor.American Journal of Ophthalmology. 135(5):747-48, 2003.
  127. Shah GK, Vander J. Bilateral Presumed Endogenous Candida Endophthalmitis and Stage 3 Retinopathy of Prematurity. American Journal of Ophthalmology 135(5):747-748, 2003.
  128. Busquets MA, Shah GK, Wickens J, Callanan D, Blinder KJ, Burgess D, Grand MG, Holekamp NM, Boniuk I, Joseph DP, Thomas MA, Fish E, Bakal J, Hollands H, Sharma S. Ocular Photodynamic Therapy With erteporfin for CNV Secondary to Ocular Histoplasmosis Syndrome. Retina. 23(3)299-306, 2003.
  129. Foster WJ, Harbour JW, Holekamp NM, Shah GK, Thomas MA. Pars Plana Vitrectomy in Eyes Containing a Treated Posterior Uveal Melanoma. American Journal Ophthalmology. 136(3):471-76, 2003.
  130. Sheidow TG, Blinder KJ, Holekamp NM, Joseph D, Shah GK, Grand MG, Thomas MA, Bakal J, Sharma S. Outcome Results in Macular Hole Surgery: An Evaluation of Internal Limiting Membrane Peeling with and without ICG. Ophthalmology 110(9):1697-1701, 2003.
  131. Recchia FM, Shah GK, Eagle RC, Sivalingam A, Rischer DH. Visual and Anatomical Outcome Following Submacular Surgery for Choroidal Neovascularization Secondary to Candida Endophthalmitis. Retina 22(3):323-29, 2002.
  132. Rao PK, Shah GK, Blinder KJ. Bilateral Macular Hole Formation in a Patient with Retinitis Pigmentosa. Ophthalmic Surgery & Lasers 33:2, 152-154, 2002.
  133. Sharma S, Shah GK. Ophthaproblem. Vitamin supplementation for age-related macular degeneration. Canadian Family Physician 48:467,477-8, 2002.
  134. Virata SR, Blinder KJ, Shah GK. Diagnostic and Therapeutic Challenges, edited by McDonald HR. Retina 22(1):9297, 2002.
  135. Sharma S, Brown GC, Brown MM, Hollands H., Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. British Journal of Ophthalmology 86(5):493-496, 2002.
  136. Shah GK, Sharma S, Benson WE, Brown GC, et al. Author’s reply to visual outcome after intravitreal steroid use for postoperative endophthalmitis. Ophthalmology 2001; 108:241.
  137. Shah GK, Kleiner RC, Augsburger JJ, Manjot KG, Jampol LM. Primary Intraocular Lymphoma Seen with Transient White Fundus Lesions Simulating the Multiple Evanescent White Dot Syndrome. Archives of Ophthalmology 119:617-620, 2001.
  138. Shah GK, Walsh AW. Lipemia Retinalis. Ophthalmic Surgery and Lasers 32(1):77-78, 2001.
  139. Shah GK, Penne R, Grand MG. Purtscher’s Retinopathy Secondary to Airbag Injury. Retina 21(1):68-69, 2001.
  140. Fineman MS, Sharma S, Shah GK, Brown GC, Eagle RC. Ultrasound Biomicroscopic Diagnosis of an Occult Intrascleral Foreign Body: An Unusual Case of ocular Siderosis. Retina 21(3):265-67, 2001
  141. Connolly BP, McNamar JA, Shah GK, Baumal CR. Retinal Detachment with a Dislocated Posterior Chamber Intraocular Lens. Archives of Ophthalmology 119:909-911, 2001.
  142. Aldave AJ, Stein JD, Deramo VA, Shah GK, Fischer DH, Maguire JI. Postoperative Propionibacterium acnes Endophthalmitis – Letter to the Editor response. Ophthalmology 108(4):633-634, 2001.
  143. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The Cost-effectiveness of Photodynamic Therapy for Fellow Eyes with Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration. Ophthalmology 108:2051-2059, 2001.
  144. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK, Sharma SM. Improvement in quality of life from photodynamic therapy: a Canadian perspective. Canadian Journal of Ophthalmology 36:332-338, 2001.
  145. Sharma S, Hollands H, Brown GC, Brown MM, Shah GK, Sharma SM. The Cost-effectiveness of early vitrectomy for the Treatment of Vitreous Hemorrhage in Diabetic Retinopathy. Current Opinion in Ophthalmology 12:230-234, 2001.
  146. Shah GK, Sharma S, Brown GC. Choroidal neovascularization following argon laser photocoagulation for macular edema associated with branch retinal vein obstruction. Canadian Journal of Ophthalmology 35(7):427-430, 2000.
  147. Shah GK, Stein JD, Sharma S, Sivalingam A, Benson WE, Regillo C, Brown GC, Tasman W: Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 107:3; 486-489; 2000.
  148. Shah GK. Adventitial sheathotomy for treatment of macular edema associated with branch retinal vein occlusion. Current Opinion in Ophthalmology 11:171-174, 2000.
  149. Shah GK, Regillo C, Tasman WS. Uncovering an Unfortunate Inheritance. Eyenet 8:39-40, 2000.
  150. Shah GK, Sharma S, Fineman MS, Federman J, Brown M, Brown GC. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. American Journal of Ophthalmology 129:1;104-106, 2000.
  151. Shah GK, Vander J, Eagle RC. Intralenticular Candida species abscess in a premature infant. American Journal of Ophthalmology. 129:390-391, 2000.
  152. Deramo VA, Shah G K, Baumal CR, Fineman MF, Corrêa ZM, Benson WE, Rapuano CJ, Cohen EJ, Augsburger JJ. The role of ultrasound biomicroscopy in ocular trauma. Transactions of the American Ophthalmological Society 129:390-391, 2000.
  153. Connolly BP, Krishnan A, Shah GK, Whelan J, Brown GC, Eagle RC, Shakin EP. Characteristics of patients presenting with central retinal artery occlusion with and without giant cell arteritis. Canadian Journal of Ophthalmology 35:379-384, 2000.
  154. Sharma S, Brown GC, Brown MM, Shah GK, Snow K, Brown H, Holland H. Converting visual acuity to utilities. Canadian Journal of Ophthalmology 35:267-72, 2000.
  155. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Current Opinion in Ophthalmology 11:175-179, 2000.
  156. Shah GK, Camarata P, Walsh AW. Branch Retinal Artery Occlusion: Angiographic Demonstration of Increased Retinal Blood Flow after External Carotid Endarterectomy. Canadian Journal of Ophthalmology 34:36-39, 1999.
  157. Shah GK, Fischer DF, Fineman MS, Sharma S, Maguire J. Subretinal neovascularization secondary to candida endophthalmitis: Long term follow-up after submacular surgery. Retina 19:81-3, 1999.
  158. Vander J, Shah GK. An update on endophthalmitis. Review of Ophthalmology 7:78-79, 1999.
  159. Deramo VA, Shah GK, Baumal CR, Correa ZM, Fineman MF, Benson WE, Cohen EJ, and Augsburger JJ. Ultrasound biomicroscopy as a tool for detecting and localizing occult foreign bodies after ocular trauma. Ophthalmology 106:301-306, 1999.
  160. Deramo V, Shah GK, Maguire J. Good Visual Outcome after Listeria monocytogenes endogenous endophthalmitis. Retina 19:566-568, 1999.
  161. Linebarger EJ, Hardten DR, Shah GK, Lindstrom RL. Phacoemulsification and modern cataract surgery. Survey of Ophthalmology 44:123-147, 1999.
  162. Brown MM, Brown GC, Sharma S, Shah GK: Utility values and diabetic retinopathy. American Journal of Ophthalmology 128:324-330, 1999.
  163. Aladave T, Stein J, Deramo V, Shah GK, Maguire J, Fischer D. Treatment strategies for postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 106:2395-2401, 1999.
  164. Shah GK, Shields JS, Lanning RL. Branch retinal vein obstruction to retinal arteriovenous communication. American Journal of Ophthalmology. 126:446-448, 1998.
  165. Shah GK, Sharma S, Brown GC. Iris neovascularization following branch retinal artery occlusion. Canadian Journal of Ophthalmology. 33:389-90, 1998.
  166. Shah GK, Auerbach DB, Augsburger JJ, Savino PJ. Acute thioridazine retinopathy. Archives of Ophthalmology. 116:826-827, 1998.
  167. Shah GK, Fischer D, Lucier A. Systemic therapy: Ocular toxicity. Current Concepts in Ophthalmology. 6:49-53, 1998.
  168. Shah GK, Vander J. Rhegmatogenous retinal detachments in cytomegalovirus retinitis. Current Opinion in Ophthalmology. 9:6-10, 1998.
  169. Shah GK, Summers GC, Walsh AW, Neely KA. Optic nerve neovascularization in incontinentia pigmenti. American Journal of Ophthalmology 124:410-412, 1997.
  170. Neely K, Shah GK, Wirtschafter JD, Walsh AW. Capillary hemangioma of the optic nerve head. Retina 17:154-159, 1997.
  171. Shah GK, Pfister DR, Probst LE, Ferrieri P, Holland EJ. Diagnosis of Microsporidium keratitis by confocal microscopy and the chromatrope stain. American Journal of Ophthalmology 121:89-91, 1996.
  172. Shah GK, Cantrill H, Holland EJ. Vortex keratopathy associated with atovaquone. American Journal of Ophthalmology 120:669-671, 1995.
  173. Tsukahara Y, Blair NP, Spellman D, Moy JJ, Takahashi A, Shah GK, Viana MAG: Ketamine suppresses ischemic injury in the rabbit retina. Investigative Ophthalmology and Visual Science 33:1822-1825, 1992
Abstracts
  1. Gautam Vangipuram, MD; Charles Li, BA; Lynn Liu; Linda D Harrison, PHD; Flora Lum MD; Gaurav K. Shah MD Timing of Delayed Retinal Break in Patients Presenting With Acute Posterior Vitreous Detachment in the IRIS® Registry AAO 2021 New Orleans, LA November 12-15, 2021- Best Poster
  2. Shieh, WS, Jeroudi, AM, Chen, YC, Connors, DB, Gonzalez, M, Lauber, C, Blinder, KB, Shah, GS Evolution of Anesthetic Approch in 27-Gauge Pars Plana Vitrectomy ASRS 35th Annual Meeting Boston, Massachusetts August 11-15, 2017
  3. Chen, Y, Blinder, KJ, Shah, GK Outcomes and Practice preference After Anti-VEGF Injection Endophthalmitis ASRS August 9-14, 2016 San Francisco, CA - Poster
  4. Jeroudi, A, Blinder, KJ, Shah, GK Management of Degenerative Retinoschisis Associated with Retina Detachment ASRS August 9-14, 2016 San Francisco, CA – Poster
  5. Jeroudi, A, Blinder, KJ, Shah, GK Epiretinal Membrane Formation Following Treatment of Retinal Breaks ASRS August 9-14, 2016 San Francisco, CA - Poster
  6. Chinskey, ND, Shah, GK Epiretinal Membrane Peeling in Patients with Good Starting Pre-op Vision AAO November 13-15, 2015 Las Vegas, Nevada - Poster
  7. Ho, VY, Wehmeier, JD, Shah, GK Wide-Field Infrared Imaging: A Descriptive Review of Characteristics of Retinoschisis, Retinal Detachment and Schisis Detachments AAO November 13-15, 2015 Las Vegas, Nevada - Poster
  8. Ho, VY, Shah, GK Short- and Long-term Outcomes of Vitreoretinal Surgeries with Deferred First Postoperative Examinations ASRS July 10 – 14, 2015 Vienne, Austria - Poster
  9. Shah, GK, Chinskey, ND Epi-Retinal Membrane Peeling in Patients with Good Starting Pre-op Vision ASRS July 10 – 14, 2015 Vienne, Austria - Poster
  10. Shah, GK, Rajagopal, R, Blinder, KJ, Walia, HS, Kolkarni, A, Gangaputra, S, Altaweel, M Macular Edema from Retinal Vein Occlusion (CRAVE): Results of a Prospective Multicenter Rendomized Clinical Trial The Retina Society Annual Meeting Philadelphia, Pennsylvania - Poster
  11. Walia, HS, Shah, GK, Blinder, KJ Characteristics and Outcomes of Sequential Rhegmatogenous Retinal Detachments The Retina Society Annual Meeting September 12, 2014 Philadelphia, Pennsylvania - Poster
  12. Masour, AM, Arevalo, JF, Moorthy, RS, Shah_GK, Zegarra, H, Pulido, J, Bou-Ghannam, A, Charbaji, A, Amselem, L, Lavaque, A, Casella, A, Ahmad, B, Paschall, J, Caimi, A, Staurenghi, G Paraproteinemic Maculopathy: Multicenter Study & Literature Review AAO 2014 Chicago, Illinois - Poster
  13. Mansour, A, Arevalo, JF, Badal, J, Moorthy, R, Shah_GK, Zegarra, H, Pulido, J, Bou-Ghannam, A, Amselem, L, Lavaque, A, Casella, A, Ahmad, B, Paschall, J, Caimi, A, Staurenghi, G. Maculopathy in Paraproteinemia AAO 2014 Chicago, Illinois - Poster
  14. Walia, HS, Liu, EM, Smith, BT, Blinder, KJ, Thomas, MA, Shah_GK, Aflibercept for AMD: Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results August 9-13, 2014 ASRS San Diego, California
  15. Walia, HS, Blinder, KJ, Shah_GK, Treatment of CNV Secondary to Presumed Ocular Histoplasmosis with Eylea 2.0 mg August 9-13, 2014 ASRS San Diego, California
  16. Ahmad, BU, Meyer, JC, Shah GK, Blinder, KJ Laser Therapy vs. Observation for Symptomatic Retinal Artery Macroaneurysms August 24-28, ASRS Annual Meeting Toronto, Ontario, Canada
  17. Meyer, JC, Shah, GK, Blinder, KJ, Waheed, NK, Reichel E, Stalmans, P, Singer, M. Tewari, A Early evolution of the Vitreomacular Interface and Clinical Efficacy after Ocriplasmin Injection for Symptomatic Vitreomacular Adhesion
  18. Ahmad, BU, Meyer, JC, Shah GK, Blinder, KJ Trends in Choice of Surgical Technique and Reimbursement for Retinal Detachment Repair August 24-28, 2013 ASRS Annual Meeting Toronto, Ontario, Canada
  19. Ahmad, BU, Meyer, JC, Shah GK, Comparison of Viscous Tetacaine vs. Viscous Lidocaine as Topical Anesthesia for Intravitreal Injections August 24-28, 201ASRS Annual Meeting Toronto, Ontario, Canada
  20. Rao RC, Shah GK Rhegmatogenous Retinal Detachment May 5-9, 2013 ARVO Annual Meeting Seattle, Washington
  21. Meyer JC, Ahmad BU, Blinder KJ, Shah GK Laser Therapy vs. Observation for Symptomatic Retinal Artery Macroaneurysms May 5-9, 2013 ARVO Annual Meeting Seattle, Washington
  22. Blinder KJ, Rao RC, Shah_GK, Smith BT Internal Limiting Membrane Peeling for Primary Rhegmatogenous Retinal Detachment Repair February 27-March 2, 2013 36th Annual Macula Society Meeting Dana Point, CA
  23. Shah GK, Rao, RC ILM Peel for RD - Video: Clip 06.38.01 Yanoff & Duker – Elsevier
  24. Shah GK – Co Author “Triamcinolone Acetonide-Assisted Internal Limiting Membrane Peeling During Primary Rhegmatogenous Retinal Detachment Repair to Reduce Postoperative Macular Pucker Formation” AAO Annual Meeting November 11, 2012 – Chicago, IL – Poster
  25. Rao RC, Blinder KJ, Smith BT, Shah GK. “Triamcinolone acetonide-assisted internal limiting membrane peeling during primary Rhegmatogenous detachment repair or reduce postoperative macular pucker formation.” 30th Annual Meeting of the American Society of Retina Specialists, Las Vegas, NV, August 25-29, 2012
  26. Rajagopal R, Blinder KJ, Shah GK. Adjuctive Therapy with Topical Nepafenac after Membrane Stripping Surgery for Macular Edema Due to Epiretinal Membranes. ARVO Annual Meeting 2012. Poster
  27. James AS, Peters CM, Tran I, Kambarian J, Colman S, Apte RS, Blinder KJ, Shah GK, Kymes SM. The Impact of Diabetic Macular Edema on the Daily Lives of Diabetic Adults—A Qualitative Study. ARVO Annual Meeting 2012. Poster
  28. Kymes SM, Peters CM, James AS, Tran I, Apte RS, Blinder KJ, Shah GK, Kambarian J, Turpcu A, Colman S. The Willingness to Pay for the Prevention of Visual Impairment Among Community Members. ARVO Annual Meeting 2012. Poster
  29. Kim BM, Shah GK. Serial Spectral Domain OCT Following Treatment of Retinal Vein Occlusion with Dexamethasone Intravitreal Implant. ASRS 29th Annual Meeting – Boston, MA August 20, 2011. Poster
  30. Jonisch J, Sivaraman K, Blinder KJ, Shah GK. Complications of Retinal Detachment Surgery Using Scleral Buckles. AAO Annual Meeting 2010. Poster
  31. Rajagopal R, Davies J, Shah GK, Blinder KB. Subretinal Tissue Plasminogen Activator and Bevacizumab for Large Subretinal Hemorrhage from Neovascular Age-Related Macular Degeneration. ARVO Annual Meeting 2010. Poster
  32. Davies J, Shah GK. Scleral Depression with 23 Gauge External Illumination. ARVO Annual Meeting 2010. Film Festival Winner.
  33. Jonisch J, Blinder KJ, Shah GK, Walsh AC. Anatomic Outcomes Using Spectral Domain OCT Following Treatment for Exudative Age-Related Macular Degeneration. ARVO Annual Meeting 2010. Poster
  34. Sivaraman K, Jonisch J, Blinder KJ, Shah GK. Complications of Retinal Detachment Surgery Using Scleral Buckles. ARVO Annual Meeting 2010. Poster
  35. Almony A, Blinder KJ, Shah GK, Sharma S. Recurrent Retina Detachment: Does Initial Treatment Matter? AAO Annual Meeting 2009. Poster.
  36. Almony A, Mansouri A, Shah GK, Blinder KJ, Sharma S. Recurrent Retinal Detachment: Does Initial Treatment Matter? ASRS Retina Congress 2009. Scientific Abstract.
  37. Shah GK, Jonisch J, Blinder KJ, Walsh AC. Anatomic Outcomes Using Spectral Domain OCT in Mono Versus Combination Therapy for Exudative AMD. ASRS Retina Congress 2009. Poster.
  38. Blinder KJ, Rajagopal R, Davies JB, Shah GK. Subretinal Tissue Plasminogen Activator and Bevacizumab for Large Subretinal Hemorrhage from Wet Age-Related Macular Degeneration. ASRS Retina Congress 2009. Poster.
  39. Almony A, Mansouri A, Shah GK, Blinder KJ. Efficacy of Intravitreal Bevacizumab After Failed Intravitreal Ranibizumab Treatment. AAO Annual Meeting 2008. Scientific Abstract.
  40. Tewari A, Almony A, Shah GK. Macular Hole Closure with Triamcinolone-Assisted Internal Limiting Membrane Peeling. AAO Annual Meeting 2008. Scientific Abstract.
  41. Shah GK, Fintak DR. Incidence of Cystoid Macular Edema Related to Surgery for Retained Lens Fragments Combined with Peeling of the Internal Limiting Membrane. AAO Annual Meeting 2008. Poster.
  42. Mehta S, Blinder KJ, Rybak MC, Fintak DR, Shah GK, Grand MG. Pars Plana Vitrectomy Versus Combined Pars Plana Vitrectomy and Scleral Buckle for Repair of Primary Rhegmatogenous Retinal Detachment. AAO Annual Meeting 2008. Poster.
  43. Almony A, Tewari A, Shah GK. Macular Hole Closure with Triamcinolone-Assisted Internal Limiting Membrane Peeling. The Retina Society 41st Annual Scientific Meeting, 2008. Abstract.
  44. Fintak D, Shah GK, Blinder KB, Regillo C, Pollack J. Incidence of Endophthalmitis Related to Intravitreal Injection of Bevacizumab and Ranibizumab. The Retina Society 41st Annual Scientific Meeting, 2008. Poster.
  45. Schadlu R, Shah GK. IOP Stability After 23-Gauge Transconjunctival Vitrectomy Surgery. ARVO 2008. Poster.
  46. Singh CN, Tewari A, Shah GK. Challenges With Pars Plana Vitrectomy Through Presbyopia Correcting Intraocular Lens. ARVO 2008. Poster.
  47. Mehta S, Blinder JK, Shah GK, Kymes S. Intravitreal Bevacizumab for the Treatment of Refractory Diabetic Macular Edema. ARVO 2008. Poster.
  48. Almony A, Shah GK, Blinder KJ. Limited Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes. ARVO 2008. Poster.
  49. Schadlu R, Shah GK, Tehrani S. ILM Peeling During Vitrectomy Surgery for Premacular Fibroplasia – Long-term Follow-up Results. ASRS 25th Annual Meeting 2007. Scientific Poster Abstract.
  50. Tewari A, Shah GK. Visual Outcomes with 23-gauge Transconjunctival Sutureless Vitrectomy. ASRS 25th Annual Meeting 2007. Scientific Poster Abstract.
  51. Schadlu R, Blinder K, Shah GK, Sheybani A. Intravitreal Bevacizumab as Treatment for Choroidal Neovascularization in Ocular Histoplasmosis. The Retina Society Annual Meeting 2007. Poster.
  52. Smith BT, Shah GK. The Effect of Internal Limiting Membrane Removal During Primary Rhegmatogenous Retinal Detachment Repair on Macular Pucker Occurrence. The Retina Society Annual Meeting 2007. Poster.
  53. Schadlu R, Shah GK. Long-Term Follow-up of Internal Limiting Membrane (ILM) Peeling in Vitrectomy Surgery for Macular Pucker. The Retina Society Annual Meeting 2007. Poster.
  54. Tewari A, Shah GK. Visual Outcomes with 23-Gauge Transconjunctival Sutureless Vitrectomy. The Retina Society Annual Meeting 2007. Poster.
  55. Smith BT, Shah GK, Blinder KJ. Efficacy of Anti-Vascular Endothelial Growth Factors Combined with Verteporfin Photodynamic Therapy for CNV in AMD. AAO Annual Meeting 2007. Poster.
  56. Shah GK, Tewari A, Fang A, Dhalla MS. Patients Treated with 23-Gauge Transconjunctival Sutureless Vitrectomy for Various Posterior Segment Conditions. Macula Society 30th Annual Meeting, 2007.
  57. Shah GK, Dhalla M, Blinder K, Mittra R, Ryan E. Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration. Seventh Euretina Congress, May 2007.
  58. Dayani PN, Shah GK, Tewari A, Blinder KJ, Hollands H, Sharma S. Long-Term Efficacy of Photodynamic Therapy with Verteporfin for Ocular Histoplasmosis Syndrome. ARVO 2007. Poster.
  59. Schadlu R, Sheybani A, Shah GK, Blinder KJ. Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome. ARVO 2007. Poster.
  60. Tewari A, Shah GK, Fang A, Dhalla MS. Visual Outcomes with 23-Gauge Transconjunctival Sutureless Vitrectomy. ARVO 2007. Poster.
  61. Shah GK, Blinder KJ, Ryan Jr EH, Mittra RA, Tewari A. Combined Intravitreal Bevacizumab and Photodynamic Therapy with Verteporfin for Choroidal Neovascularization in Age Related Macular Degeneration. ARVO 2007. Poster.
  62. Shah GK. Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration. Masters of the ASRS 2007. Paper
  63. Vemulakonda GA, Hariprasad SM, Mieler WF, Princer RA, Shah GK, Van Gelder RN. Determination of Aqueous and Vitreous Concentration of Topically Administered 1% Voriconazole in Humans. AAO 2006. Paper.
  64. Dayani PN, Blinder KJ, Shah GK, Holekamp NM, Thomas MA, Joseph DP, Grand MG. Surgical Outcome of Scleral Buckle Compared with Scleral Buckle with Vitrectomy for the Treatment of Macula-Off Retinal Detachment. AAO 2006. Poster.
  65. Dhalla MS, Shah GK, Patel A, Blinder KJ, Tewari A. Photodynamic Therapy with Verteporfin Combined with Posterior Juxtascleral Triamcinolone Acetonide for Choroidal Neovascularization. ARVO 2006. Poster.
  66. Tewari A, Shah GK, Patel A, Dhalla MS, Sharma S. Management of Inferior Rhegmatogenous Retinal Detachments: Scleral Buckle vs. Combined Pars Plana Vitrectomy and Scleral Buckle. ARVO 2006. Poster.
  67. Wickens JC, Shah GK. Outcomes of Macular Hole Surgery and Shortened Prone Positioning. American Academy of Ophthalmology Meeting. October 2005. Poster.
  68. Wickens JC, Blinder KJ, Shah GK. Triamcinolone Assisted Internal Limiting Membrane Peeling in Macular Hold Surgery. American Academy of Ophthalmology Meeting. September 2005. Poster.
  69. Prasad AG, Burgess DB, Shah GK. Optical Coherence Tomography (OCT) Characteristics in Central Serous Chorioretinopathy. Retina Society Annual Meeting. September 2005. Paper Presentation.
  70. Wickens JC, Shah GK. Triamcinolone Assisted Internal Limiting Membrane Peeling in Macular Hole Surgery. Retina Society Annual Meeting. September 2005. Poster.
  71. Wickens JC, Shah GK. Outcomes of Macular Hole Surgery and Shortened Prone Positioning. Retina Society Annual Meeting. September 2005. Poster.
  72. Ahmad OR, Wickens JC, Blinder KJ, Shah GK. Triamcinolone Assisted Internal Limiting Membrane Peeling in Macular Hole Surgery. ARVO Annual Meeting. May 2005. Poster.
  73. Prasad A, Shah GK. OCT Characteristics in Central Serous Chorioretinopathy. ARVO Annual Meeting. May 2005. Poster.
  74. Wickens JC, Shah GK. Macular Hole Surgery with Internal Limiting Membrane Peeling and Three Day Prone Positioning. ARVO Annual Meeting. May 2005. Poster.
  75. Shah GK. VEGF agents and Macugen. 12th Annual Conference of Bombay Ophthalmologists’ Association, Sahar, Mumbai, India. December 5, 2004. Paper Presentation
  76. Shah GK. Use of Voriconazole for Fungal Endophthalmitis. Paper Presentation and Discussion on All Clinical Aspects of Endophthalmitis. 12th Annual Conference of Bombay Ophthalmologists’ Association, Sahar, Mumbai, India. December 5, 2004.
  77. Shah GK, Rosenblatt BJ, Blinder KB, Grand MG, Holekamp NM. Demonstration of Internal Limiting Membrane Peeling With the Use of Triamcinolone Acetonide: A Novel Approach. American Academy of Ophthalmology Annual Meeting. October 2004. Poster.
  78. Shah GK. Long Term Visual Outcomes and Complications of Epiretinal Membrane Removal Secondary to Rhegmatogenous Retinal Detachment. American Academy of Ophthalmology Annual Meeting. October 2004. Poster.
  79. Shah GK, Council M, Lee HC, Sharma S, Bakal J. Visual Outcomes and Complications of Epiretinal Membrane Removal Secondary to Rhegmatogenous Retinal Detachment. Retina Society Meeting. September 2004. Poster Presentation.
  80. Shah GK, Rosenblatt B, Blinder KJ, Smith M. The Use of Intraoperative Triamcinolone for Internal Limiting Membrane Peeling. American Society of Retina Specialists Annual Meeting. August 2004. Paper.
  81. Shah GK, Lee HC. Intravitreal Triamcinolone as Primary Treatment for Cystoid Macular Edema Secondary to Branch Retinal Vein Occlusion. American Society of Retina Specialists Annual Meeting. August 2004. Poster.
  82. Hariprasad SM, Shah GK. Treatment of Juxtafoveal Choroidal Neovascularization with Photodynamic Therapy Using Verteporfin in Eyes with Age-related Macular Degeneration. American Society of Retina Specialists Annual Meeting. August 2004. Poster.
  83. Prasad AG, Hariprasad SM, Grand MG, Apte RS, Van Gelder RN, Smith M, Shah GK. Bilateral Choroiditis from Protect Algaemia. American Society of Retina Specialists Annual Meeting. August 2004. Poster
  84. Council M, Shah GK, Lee HC, Sharma S. Visual Outcomes and Complications of Epiretinal Membrane Removal Secondary to Rhegmatogenous Retinal Detachment. ARVO Annual Meeting. April 2004. Poster 2044/B855.
  85. Sharma S, Bakal J, Brown G, Shah GK, Dugar A. Economic Resources Utilized in a Cohort of Patients with Age-Related Macular Degeneration. ARVO Annual Meeting. April 2004. Poster 1410/B221.
  86. Mieler WF, Gao H, Pennesi M, Iyer M, Hariprasad SM, Grand MG, Shah GK, Blinder KB, Holekamp NM, Thomas MA, Apte RS. Moxifloxacin: Topical and Intravitreal Administration. 27th Annual Meeting of The Macula Society, Feb. 25-28, 2004.
  87. Grand MG, Hariprasad SM, Shah GK, Mieler WF. The Role of Systemic and Intravitreal Voriconazole in the Management of Endogenous Fungal Endophthalmitis. 27th Annual Meeting of The Macula Society, Feb. 25-28, 2004.
  88. Grand MG, Shah GK, Cooper B, Rosenblatt B. Visual Outcomes After Multiple Vitrectomies. The Retina Debates 2003, Subspecialty Day. November 14-15, 2003.
  89. Shah GK, Rosenblatt B, Blinder KJ. Photodynamic therapy for the treatment of peripapillary choroidal neovascularization. Poster presentation.36th Scientific Session of The Retina Society, Sept. 18-21, 2003.
  90. Shah GK, Rosenblatt B, Sharma S, Blinder KJ. Photodynamic therapy for the treatment of peripapillary choroidal neovascularization. Poster presentation.21st Annual Meeting American Society of Retina Specialists, Aug. 16-20, 2003.
  91. Shah GK, Rosenblatt B, Sharma S, Blinder KJ. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Poster presentation. 21st Annual Meeting American Society of Retina Specialists, Aug. 16-20, 2003.
  92. Rao PK, Shah GK, Cooper B, Smith M. Histologic and ultrastructural features of a vitreous cyst. Poster presentation. 21st Annual Meeting American Society of Retina Specialists, Aug. 16-20, 2003.
  93. Shah GK. Photodynamic Therapy for Histoplasmosis and subsequent panel discussion. 6th International Advanced Vitreo Retinal Surgery Course, Chennai, India. July 24, 2003.
  94. Rosenblatt BJ, Shah GK, Sharma S. Pars Plana Vitrectomy with Internal Limiting Membranectomy for Diabetic Macular Edema. Poster presentation #4004. ARVO 2003.
  95. Cooper BA, Shah GK, Rao PK, Smith M. Vitreous Cyst. Verhoeff/Zimmerman Society Meeting. March 2003.
  96. Shah GK, Thomas MA, Grand MG, Blinder KJ, Ryan EH, Lagouros PA, Minturn JT, Sharma S. The Use of Photodynamic Therapy for the Management of Juxtafoveal Choroidal Neovascularization Secondary to Ocular Histoplasmosis. Retina/Vitreous Combined Meeting Sept. /Oct. 2002.
  97. Shah GK, Cooper B, Grand MG, Sharma S. Visual Outcomes and Complications Following Multiple Vitrectomies for Diabetic Vitreous Hemorrhage. Poster 03-15. Retina/Vitreous Combined Meeting Sept/Oct. 2002.
  98. Blinder KJ, Shah GK, Thomas MA, Holekamp NM, Rao PK, Joseph DP, Grand MG. Surgical Removal of Peripapillary Choroidal Neovascularization Associated with Age-Related Macular Degeneration. AAO Annual Meeting 2002. Poster Presentation #PO120.
  99. Foster WJ, Harbour JW, Shah GK. Pars Plana Vitrectomy in Eyes Previously Treated for Uveal Melanoma. Retina/Vitreous Combined Meeting Sept. /Oct. 2002.
  100. Sharma S, Bakal J, Brown GC, Brown MM, Sharma S, Shah GK, Oliver-Fernandez A. The Cost-Utility of High-Dose Vitamin Supplementation for “Dry” AMD. AAO Annual Meeting 2002. Paper Presentation #PA044.
  101. Sharma S, Bakal J, Brown GC, Brown MM, Sharma SM, Shah GK, Oliver-Fernandez A. The Cost-Utility of Vitamin Supplementation as Secondary Prevention for Dry Age-Related Macular Degeneration. Retina/Vitreous Combined Meeting Sept./Oct. 2002.
  102. Blinder KJ, Shah GK, Thomas MA, Holekamp NM, Joseph DP, Rao PK, Grand MG, Sharma S. Surgical Management of Peripapillary Choroidal Neovascularization Associated with Age-Related Macular Degeneration. Poster 04-02. Retina/Vitreous Combined Meeting Sept./Oct. 2002.
  103. Shah GK, Busquets MA, Wickens JC, Callanan D, Fish GE, Blinder KJ, Holekamp NM, Joseph DP, Grand MG, Thomas MA, Sharma S. Photodynamic therapy for Choroidal Neovascularization in Ocular Histoplasmosis. Vitreous Society Meeting December 1, 2001. Paper Presentation.
  104. Sheidow TG, Blinder KJ, Holekamp NM, Joseph DP, Shah GK. Outcome Results in Macular Hole Surgery: An Evaluation of Internal Limiting Membrane Peeling With and Without ICG. Vitreous Society Meeting. November 28, 2001
  105. Busquets MA, Shah GK, Wickens JC, Blinder KJ, Boniuk I, Burgess DB, Grand MG, Holekamp NM, Joseph DP, Thomas MA, Sharma S. Photodynamic therapy for choroidal Neovascularization following Thermal Laser Treatment. Vitreous Society Meeting. November 30, 2001.
  106. Rao PK, Shah GK, Lubniewski AJ. Outcomes of Corneal Ulcer Related Endophthalmitis. Vitreous Society Meeting. December 1, 2001.
  107. Blinder KJ, Wickens JC, Busquets MA, Shah GK, Burgess DB, Grand MG, Holekamp NM, Joseph DP, Thomas MA, Holland H, Sharma S. Photodynamic Therapy for Subfoveal Choroidal Neovascularization in Pathologic Myopia. Vitreous Society Meeting. December 1, 2001.
  108. Brantley, Jr. MA, Holekamp NM, Shah GK, Burgess DB: Increased Retinal Perfusion after Arteriovenous Sheathotomy for Branch Retinal Vein Occlusion. AAO Annual Meeting. November 2001.
  109. Cooper BA, Sheidow TG, Grand MG, Sharma S, Shah GK: Outcomes of Macular Hole Surgery in Diabetic Patients. Poster 305. AAO Annual Meeting. November 2001.
  110. Busquets MA, Wickens J, Shah GK, Blinder KJ, Burgess D, Grand MG, Holekamp NM, Joseph DP, Thomas MA, Sharma S. Photodynamic Therapy for Subfoveal CNV in Ocular Histoplasmosis. 2372-B622, ARVO 2001.
  111. Busquets MA, Wickens J, Shah GK, Blinder KJ, Burgess D, Grand MG, Holekamp NM, Joseph DP, Thomas MA, Sharma S. Photodynamic Therapy for Subfoveal CNV in Myopic Degeneration. 2376-B626, ARVO 2001.
  112. Virata SR, Shah GK, Cooper BA, Busquets MA, Blinder KJ, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Thomas MA, Sharma S. Retinal Detachments in Fellow Eyes of Patients with Pseudophakic Retinal Detachments. Poster, AAO Annual Meeting, October 24, 2000, Dallas, Texas.
  113. Virata SR, Cooper BA, Busquets MA, Blinder KJ, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Thomas MA, Shah GK. Retinal Detachments in Fellow Eyes of Patients with Pseudophakic Retinal Detachments [ARVO Abstract]. Invest Ophthalmology Vis Sci 41(4): S664. Abstract 3528.
  114. Sharma S, Amjadi K, Shah GK, Augsberger J, ten Hove M, Cruess AF. Ischemic versus nonischemic CRVO: Results of a survival analysis. Canadian Ophthalmology Society Annual Meeting (Halifax, Nova Scotia) 1999.
  115. Sharma S. Amjadi K, ten Hove MW, Shah GK, Cruess AF. Mortality rates in central retinal vein occlusion: results of a cohort study. Canadian Ophthalmology Society Annual Meeting (Halifax, Nova Scotia) 1999.
  116. Shah GK, Stein JD, Benson WE, Sivalingam A, Sharma S, Regillo C: Visual outcomes following the use of intravitreal steroids in the treatment of acute post-operative endophthalmitis. Presented at Association for Research in Vision and Ophthalmology Meeting, 27, May 1999 and Retina Society Meeting, December 1999.
  117. Shah GK, Sharma S, Fineman MF, Brown GC: Surgical decompression for reversal of branch retinal vein obstruction. Presented at the Wills Eye Hospital Clinical Conference March 1998 and the Association for Research in Vision and Ophthalmology Meeting May 1998.
  118. Shah GK, Augsburger JJ, Fischer D, Sharma S, Eagle RC: Diagnostic vitrectomy for suspected primary intraocular lymphoma. Presented at the Retina Society Meeting September 1998.
  119. Deramo VA, Shah GK, Baumal CR, Correa ZM, Fineman MF, Benson WE, Cohen EJ, and Augsburger JJ. Ultrasound biomicroscopy as a tool for detecting and localizing occult foreign bodies after ocular trauma. Presented at the American Ophthalmological Society and at the Association for Research in Vision and Ophthalmology Meeting May 1998.
  120. Augsburger JJ, Shah GK, Fineman MF, Sharma S, Freire J, Brady LW: Relative effectiveness of plaque radiotherapy versus enucleation by long- term follow-up. Presented at the Meeting of the Club Jules Gonin 1998.
  121. Neely KM, Shah GK: Cytomegalovirus retinitis in pancreas transplant patients.In: American Academy of Ophthalmology 100th Annual Meeting Program 1996, October 27-31; Chicago. Philadelphia (PA): Lippincott-Raven 1996: Abstract nr pp 163.
  122. Hardten DR, Shah GK, Muller HA, Dougherty PJ, Schneider TL, Lindstrom RL: Evaluation of penetrating keratoplasty utilizing Hessburg-Barron trephine versus Hanna trephine using 10-0 nylon versus 11-0 mersilene suture. Investigative Ophthalmology and Visual Science 37(3): S550, 1996.
  123. Shah GK, Tsukahara Y, Blair NP, Fiscella R, Moy JJ, Viana MAG: Effects of the Lazaroid U75412E on ischemic retinal injury. Investigative Ophthalmology and Visual Science 32(4): S1030, 1991.
  124. Tsukahara Y, Blair NP, Spellman D, Shah GK, Moy JJ, Viana MAG: Ketamine suppresses ischemic injury in the rabbit retina. Investigative Ophthalmology and Visual Science 32(4): S1031, 1991.
Lectures/Seminars
  1. Management of Vision-Obscuring Vitreous Hemorrhage Associated with Posterior Vitreous Detachment: Observe or Operate? AAO 2021 Virtual Retina Subspecialty Day November 12, 2021
  2. AMD Speaker Annual Congress of Ophthalmology-Bogota, DC - virtual March 2021
  3. Neovascular AMD Moderator- Panel discussion AAO 2020 Virtual Retina Subspecialty Day November 13, 2020
  4. Scleral Buckling vs No Buckle in Vitreo-Retinal Surgery: The Debate World Ophthalmology Congress 2020 Virtual June 28, 2020
  5. Vitrectomy 27g: Evolution and Revolution Annual Congress of Ophthalmology – Bogota, DC January 30- February 1, 2020
  6. Complications of Intravitreal injections: Infections and Bubbles of Silicone Oil – New Observations Annual Congress of Ophthalmology – Bogota, DC January 30- February 1, 2020
  7. Retinal Drug Toxicity Annual Congress of Ophthalmology – Bogota, DC January 30- February 1, 2020
  8. Vitrectomy for the Management of Diabetic Macular Edema- Is it useful? Annual Congress of Ophthalmology – Bogota, DC January 30- February 1, 2020
  9. Retinal Tears and Detachments Annual Congress of Ophthalmology – Bogota, DC January 30- February 1, 2020
  10. The Buckle Symposium The Pro Study-Design, Outcomes and IV XCmplications for treatment Vitreo-Retinal Society- India December 5-8, 2019 India
  11. The ASRS-VRSI Session: “Getting out of Jail” Managing Surgical Complications/Complicated Situations Vitreo-Retinal Society- India December 5-8, 2019 India
  12. Advanced VR Surgery –II “Where Eagles Dare” Surgery for Retinoschisis with Retinal Detachments Vitreo-Retinal Society- India December 5-8, 2019 India
  13. Analysis of Emergent Non-Hospital Based Retina Consultation Requests in a Academic Non-Hospital Associated Retina Practice The Retina Society September 11-15. 2019 London, UK
  14. Vit a Toxicity Case Presentation Midwest Ocular Angiography Conference July 7-9, 2019 Jackson Hole, WY
  15. lmiron Toxicity: A New Entity Midwest Ocular Angiography Conference July 7-9, 2019 Jackson Hole, WY
  16. Live Surgery Osaka Retina May 25, 2019, Osaka, Japan
  17. ERM Formation After RD Repair: Pathology and Prevention Osaka Retina May 25, 2019, Osaka, Japan
  18. A Lot’s Changed Since 1967 VIT Buckle Society April 4-6 2019, Las Vegas, NV
  19. Is Sclera Buckling Necessary? Retina World Congress March 21-24 2019, Fort Lauderdale, FL
  20. Traction-Less Surgical Posterior Vitreous Detachment Through Hydro-dissection Vail Vitrectomy February 9- 12, 2019, Vail CO
  21. Sclerectomy to Intractable Central Serous Chorioretinopathy Panelist Vail Vitrectomy February 9- 12, 2019, Vail CO
  22. ILM Peeling During Retinal Detachment Surgery: Management of Retinal Detachment and PVR APVRS December 15, 2018 Coex, Seoul, Korea
  23. Topical 27G Vitrectomy: A useful alternative for select cases. VSRI November 30, 2018 Jaipur India
  24. Management of Non-Diabetic Vitreous Hemorrhage: Should we Wait or Operate? VSRI November 30, 2018 Jaipur India
  25. Medicolegal Aspects in the US: A Primer VSRI- ASRS Session November 30, 2018 Jaipur India
  26. Vitrectomy for Diabetic Macular Edema: Why, How, and When AAO Retina Sub Specialty 2018 October 26, 2018 Chicago, IL.
  27. Lawsuits Alleging Failure to Diagnose Retinal Detachments Midwest Ophthalmologic Symposium 2018 September 8, 2018 St. Louis, MO
  28. Parikh VS, Hang P, Shah GK. Surgical Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy Using a 2-Dimensional Cutter. Paper-on-demand at The American Society of Retinal Specialists July 20-25, 2018 Annual Meeting; Vancouver, BC, Canada.
  29. Fungal endophthalmitis update Ocular TraumaCON 2018 ITC Grand Chola, Chennai, July 13-15, 2018
  30. Principles and techniques of Vitreous endoscopic techniques Ocular TraumaCON 2018 July 13-15, 2018 ITC Grand Chola, Chennai
  31. Medical Retina Case Panel Duke Eye Center 4th Duke FAVS Course 2018 April 13 – 14, 2018 Durham, NC
  32. VR Surgical Rounds Unleashed Panel Duke Eye Center 4th Duke FAVS Course 2018 April 13 – 14, 2018 Durham, NC
  33. The Great Job Search Panel Duke Eye Center 4th Duke FAVS Course 2018 April 13 – 14, 2018 Durham, NC
  34. Private Equity – A Primer and What Is This All About Duke Eye Center 4th Duke FAVS Course 2018 April 13 – 14, 2018 Durham, NC
  35. Contract Negotiations: What Should I look for? Duke Eye Center 4th Duke FAVS Course 2018 April 13 – 14, 2018 Durham, NC
  36. Classic Duke Retina Duke Vitreoretinal Rounds Unleashed: Fellows’ Surgical Videos Duke Eye Center 4th Duke FAVS Course 2018 April 13 – 14, 2018 Durham, NC
  37. Presenter: Retina 2018: The Art + Science of Retina + Vitreous RET03 – Vitrectomy for Diabetic Macular Edema: Why, How, and When. AAO 2018 October 26 2018 Chicago, Illinois
  38. Speaker: Post Injection Endophthalmitis Session 7: Vitreoretina 27th Cairo Retina Meeting 10-12 January 2018, Cairo, Egypt
  39. Speaker: Vitrectomy for DME: are we too late? Moderator, Session 8: ASRS Symposium 7th Cairo Retina Meeting 10-12 January 2018, Cairo, Egypt
  40. Moderator: ASRS Symposium I 17th Emirates Society of Ophthalmology Conference Dubai International Convention & Exhibition Centre 14-16 December 2017, Dubai, UAE
  41. Speaker: Post Injection Endophthalmitis 17th Emirates Society of Ophthalmology Conference Dubai International Convention & Exhibition Centre 14-16 December 2017, Dubai, UAE
  42. Speaker: New Observations Moderator: ASRS Symposium I 17th Emirates Society of Ophthalmology Conference Dubai International Convention & Exhibition Centre 14-16 December 2017, Dubai, UAE
  43. Speaker: 27 g Vitrectomy: What Have We Learned So Far 17th Emirates Society of Ophthalmology Conference Dubai International Convention & Exhibition Centre 14-16 December 2017, Dubai, UAE
  44. Speaker: Peeling in Retinal Detachment: Rationale and Outcomes Moderator: ASRS Symposium I 17th Emirates Society of Ophthalmology Conference Dubai International Convention & Exhibition Centre 14-16 December 2017, Dubai, UAE
  45. Participant: Debate: Retinal Challenges with a Twist 17th Emirates Society of Ophthalmology Conference Dubai International Convention & Exhibition Centre 14-16 December 2017, Dubai, UAE
  46. Diabetic Retinopathy Symsposium Coney Gonzalez V, Stewart M, Shah G, Rachitskaya A Mediterranean Retina Meeting Mediterranean Retina VII 12-15 October 2017, Sorrento, Italy
  47. Advanced Vitroretinal Surgery Course Soni M, Bhavsar A, Tranos P, Shah G, Lazic R, Ozdek S Mediterranean Retina Meeting Mediterranean Retina VII 12-15 October 2017, Sorrento, Italy
  48. European Society of Retina Specialists 17th Annual EURETINA Congress 7-10 September 2017, CCIB, Barcelona, Spain Global Trends in Retina ASRS 35th Annual Meeting Boston, Massachusetts August 11-15, 2017
  49. Surgical Case Conference: Moderator ASRS 35th Annual Meeting Boston, Massachusetts August 11-15, 2017
  50. SB Techniques with GoPro Camera Retina Summit Taj Coromandel, Chennai July 14-15, 2017
  51. Global Trends in management of RD – Multicontinent Survey Retina Summit Taj Coromandel, Chennai July 14-15, 2017
  52. Natural History and management of Retinoschisis related RD Retina Summit Taj Coromandel, Chennai July 14-15, 2017
  53. Retinal Detachment Repair: Tips and Tricks WAVE OIC Fairmont Kea Lani Resort Maui, Hawaii June 25 – 28, 2017
  54. Post Injection Endophthalmitis: What do we do now? WAVE OIC Fairmont Kea Lani Resort Maui, Hawaii June 25 – 28, 2017
  55. Surgical Complications: Surgical Videos WAVE OIC Fairmont Kea Lani Resort Maui, Hawaii June 25 – 28, 2017 OMIC: Where are we now and going? WAVE OIC Fairmont Kea Lani Resort Maui, Hawaii June 25 – 28, 2017
  56. ASRS Session: Vascular Retinal Diseases Vitrectomy for DME- Why, How and When FLOREtina 2017 – Palazzo dei Congressi Florence, Italy April 27 – 30, 2017
  57. FLOREtina 2017 – Palazzo dei Congressi Florence, Italy April 27 – 30, 2017
  58. Debunking 27g hype- Do The Benefits of 27g Truly Outweigh the Limitations? FLOREtina 2017 – Palazzo dei Congressi Florence, Italy April 27 – 30, 2017
  59. Grand Rounds – Infrared Imaging: A New Tool 53rd Annual Physician Meeting The Pittsburgh Ophthalmology Society Pittsburgh, Pennsylvania March 17, 2017
  60. Diabetic Macular Edema – Past, Present and Future 53rd Annual Physician Meeting The Pittsburgh Ophthalmology Society Pittsburgh, Pennsylvania March 17, 2017
  61. Contemporary Management of Retinal Detachment 53rd Annual Physician Meeting The Pittsburgh Ophthalmology Society Pittsburgh, Pennsylvania March 17, 2017
  62. Retinoschisis-Related Retinal Detachment: Current Management Options Retina World Congress Fort Lauderdale, Florida February 23-26, 2017
  63. Global Trends in Retinal Detachment Repair Vitreo Retina Society-India Chandigarh, India November 30 –December 4, 2016
  64. For DME, PPV should be considered Vitreo Retina Society-India Chandigarh, India November 30 –December 4, 2016
  65. Surgical Retina – Session 2 “Surgical Strikes” Co-Chair Vitreo Retina Society-India Chandigarh, India November 30 –December 4, 2016
  66. Vitrectomy for DME: Are We Too Late Vitreo Retina Society-India Chandigarh, India November 30 –December 4, 2016
  67. Current Management of Retinoschisis related to Retina Detachments Vitreo Retina Society-India Chandigarh, India November 30 –December 4, 2016
  68. Current Management of DME in an Ever Changing World Cleveland Clinic: Retina Update November 18, 2016
  69. New Advances in Surgery on Retina Diseases Ophthalmology Associates Chesterfield, Missouri November 15, 2016
  70. Zeiss AngioPlex User Meeting Nashville, Tennessee November 11-12, 2016 AMD: Past, Present and Future Peoria Ophthalmic Society Peoria, Illinois October 27, 2016
  71. 12th Annual Ocular Imaging Conference in Conjunction with AAO - Co-Chair and Presenter. Chicago, Illinois October 16, 2016
  72. The Retina Sessions Chicago, Illinois October 14, 2016
  73. 27G: Principles and Current Applications Making Small Gauge Surgery a Reality EURetina 2016 Copenhagen, Denmark September 10, 2016
  74. AMD and the Macula 16th Annual AVTT August 26-28, 2016 Chicago, IL
  75. Vitrectomy for DME: Is it Beneficial? 16th Annual AVTT August 26-28, 2016 Chicago, IL
  76. Smaller is Definitely Better 16th Annual AVTT August 26-28, 2016 Chicago, IL
  77. Repair of Retinal Detachment: Global Trends and Evolving Concepts 16th Annual AVTT August 26-28, 2016 Chicago, IL
  78. Vitrectomy Instrument Demonstration 16th Annual AVTT August 26-28, 2016 Chicago, IL
  79. Management of Degenerative Retinoschisis Associated Retina Detachment ASRS August 7-14, 2016 San Francisco, CA
  80. Outcomes and Practice Preferences After Anti-VEGF Injection Endophthalmitis ASRS August 7-14, 2016 San Francisco, CA
  81. Retina Practice Economics: My Crystal Ball 2nd fAVS Program April 15- 16, 2016 Durham, NC
  82. Contract Negotiations (or the Idiot’s Guide to Instant Millions) 2nd fAVS Program April 15- 16, 2016 Durham, NC
  83. Primary Retinal Detachment: What to Do and Not to Do 2nd fAVS Program April 15- 16, 2016 Durham, NC
  84. Ocular Imaging: What’s new Washington Academy of Eye Physicians & Surgeons March 31 – April 1, 2016 Seattle, WA
  85. Vitreomacular Traction, ERM and Macular Holes: Current Management Washington Academy of Eye Physicians & Surgeons March 31 – April 1, 2016 Seattle, WA
  86. Retinal Vascular Occlusions: What Are We Doing Now Washington Academy of Eye Physicians & Surgeons March 31 – April 1, 2016 Seattle, WA
  87. Retinal Detachment: Management and Challenges Washington Academy of Eye Physicians & Surgeons March 31 – April 1, 2016 Seattle, WA
  88. Retinal Detachment: A Primer Canadian Retina Society 2016 March 3-6, 2016 Mont-Tremblant, Quebec
  89. Clinical Reality of Ocriplasmin Canadian Retina Society 2016 March 3-6, 2016 Mont-Tremblant, Quebec
  90. 27 Gauge Surgery: What is it all about? 30th Annual Mid-Winter Sarasota Vitreo-Retinal Update February 11-13, 2016 Sarasota, Florida
  91. Retinal Detachment Primer 30th Annual Mid-Winter Sarasota Vitreo-Retinal Update February 11-13, 2016 Sarasota, Florida
  92. Ocriplasmin: What have we Learned? 30th Annual Mid-Winter Sarasota Vitreo-Retinal Update February 11-13, 2016 Sarasota, Florida
  93. Macular Holes and Macular Pucker 30th Annual Mid-Winter Sarasota Vitreo-Retinal Update February 11-13, 2016 Sarasota, Florida
  94. Retinal Detachment Repair: A Primer with Pearls Case Western Reserve University February 9, 2016
  95. DME: Current Update Cleveland Ophthalmology Society February 9, 2016
  96. Retina Fellows’ Forum Wet Lab of Retisert Westin Chicago River North January 22-23, 2016 Chicago, Illinois
  97. Arab African Society of Retina Specialists Cairo Marriott Hotel & Omar Khayyam Casino January 14 – 16, 2016 Cairo, Egypt
  98. What’s New in Ocular Imaging January 6, 2016 Sankara Nethralaya, India
  99. Repair of Retinal Detachments: What’s New January 4, 2016 Bangalore, India
  100. Pakistan Vitreo Retinal Society Webinar December 3 – 5, 2015
  101. OIC AAO Embassy Suites Convention Center November 15, 2015 Las Vegas, Nevada
  102. Pre-Academy AAO Scleral Buckle is Preferred in Young, Phakic Retinal Detachment Patients November 13, 2015 Las Vegas, Nevada
  103. Current Management and Challenges of Retinal Detachment Repair Pan American Congress August 5-8, 2015 Bogota, Colombia
  104. Avastin vs. Lucentis in RVO Pan American Congress August 5-8, 2015 Bogota, Colombia
  105. Wave/OIC June 21- 24, 2015 Fairmont Kea Lani Resort Maui, Hawaii
  106. Celebrations Retina Celebrations Life Live Surgery May 15 – 17, 2015 Mumbai, Maharashtra, India
  107. Celebrations Retina Celebrations Life Retinal Vein Occlusions: Anti VEGF and Beyond May 15 – 17, 2015 Mumbai, Maharashtra, India
  108. Celebrations Retina Celebrations Life Ocriplasmin: Lessons learnt May 15 – 17, 2015 Mumbai, Maharashtra, India
  109. Spring Retina Update Management of Retinal Detachment May 9, 2015 Drury Inn – Brentwood, MO
  110. Routine ILM Removal in Retinal Detachment Leuven Retina Meeting April 23 – 25, 2015 Leuven, Belgium
  111. Outcome of Surgery for VMT & Macular Hole: What can patients expect? Leuven Retina Meeting April 23 – 25, 2015 Leuven, Belgium
  112. BOS Lecture/Grand Rounds April 9, 2015 Buffalo, NY
  113. Current management of Retinal Detachment 27g vitrectomy: What are we doing now? Upper Egypt Retina Meeting December 4-5, 2014 Movenpick Resort Aswan - Egypt
  114. A Look Ahead at AMD Management and Retinal Imaging: The Next Decade Wills Eye Hospital Philadelphia, Pennsylvania December 13, 2014
  115. 10th Annual Ocular Imaging Conference in Conjunction with AAO - Co-Chair and Presenter. Chicago, Illinois October 19, 2014 Rise to the Challenge: Modern Retinal Surgery Techniques
  116. Shah GK, Tewari, A., Kitchens, JW, Blinder, Jumper, JM, Carvounis, P. John Hancock Observatory, Chicago, IL October 17, 2014
  117. Macular Edema from Retinal VEIn Occlusion (CRAVE): Results of a Prospective Multicenter Rendomized Clinical Trail The Retina Society Annual Meeting Philadelphia, Pennsylvania September 12, 2014
  118. ILM Peeling: What, When, & Why? 4th Annual Chicagoland Midwest Retina Update Swissotel Chicago, IL May 17, 2014
  119. SAGE Retina Meeting Bascom Palmer Eye Institute Palm Beach Gardens, FLMarch 9, 2014
  120. Ocriplasmin: Current Clinical Experience Post Approval Macula 2014 Meeting Wills Eye Hospital Philadelphia, PA January 11, 2014
  121. Case Presentation and Panel Discussion Macula 2014 Meeting Wills Eye Hospital Philadelphia, PA January 11, 2014
  122. Diabetic Macular Edema: Past, Present and Future Current Concepts in Ophthalmology 2014 SUNY Downstate Medical Center Department of Ophthalmology Atlantic City, NJ January 10, 2014
  123. Macular Hole and ILM Surgery Updates Current Concepts in Ophthalmology 2014 SUNY Downstate Medical Center Department of Ophthalmology Atlantic City, NJ January 10, 2014
  124. Shah GK Contemporary Management of Retinal Detachment Current Concepts in Ophthalmology 2014 SUNY Downstate Medical Center Department of Ophthalmology Atlantic City, NJ January 10, 2014
  125. 9th Annual Ocular Imaging Conference in Conjunction with AAO New Orleans, LA November 2013. Co-Chair and Presenter.
  126. Shah GK, Tewari, A., Kitchens, JW, Blinder, KJ, Kunimoto, D. 3rd Annual Get Jazzed About Retina Surgery November 15, 2013 New Orleans, LA
  127. Shah GK Retina Disease Insight: Wet AMD and Macular Edema following CRVO Phoenix Ophthalmological Society November 7, 2013 Pointe Hilton Tapatio - Phoenix, AZ
  128. Shah GK Macular Holes and VMT: What’s new New Mexico Academy of Ophthalmology September 28, 2013 Albuquerque, NM
  129. Shah GK Contemporary Management of Retinal Detachment Repair New Mexico Academy of Ophthalmology September 28, 2013 Albuquerque, NM
  130. Shah GK Contemporary Management of Retinal Detachment Repair New Mexico Academy of Ophthalmology September 28, 2013 Albuquerque, NM
  131. Faculty – Shah GK, Eliott, D, SriniVas, SR Transitions into Clinical Practice for Retina Specialists September 6-7, 2013 InterContinental Chicago O’Hare Hotel Rosemont, Illinois
  132. Meyer, JC, Shah, GK Short-Term Efficacy and Safety of a Single Intravitreal Injection of Ocriplasmin in Patients With Symptomatic Vitreomacular Adhesion (VMA) August 24-28, 2013
  133. ASRS Annual Meeting Toronto, Ontario, Canada Surgical Case Conference: Panelist August 24-28, 2013 ASRS Annual Meeting Toronto, Ontario, Canada
  134. Ahmad BU, Shah GK Is There a Role for Scleral Buckling in 2013 30th Pan-American Congress Rio de Janeiro, Brazil August 7-10, 2013
  135. Ahmad BU, Shah GK Presbyopia Correcting Lenses What Retinal Surgeons Should Know 30th Pan-American Congress Rio de Janeiro, Brazil August 7-10, 2013
  136. Shah GK – Presenter: Preventing & Treating Pucker Formation after Surgery Leuven Retina Meeting May 25, 2013 Belgium
  137. Shah GK – Moderator: Live Surgery – Diabetic Retinopathy Leuven Retina Meeting May 24, 2013 Belgium
  138. Shah GK – Presenter: Washington D.C. Ophthalmological Society Pharmacologic Vitreolysis and Update on Macular Holes April 30, 2013 Washington D.C.
  139. Shah GK – Presenter: Tampa Bay Ophthalmological Society Current Rolls of Retinal Diseases March 28, 2013 Tampa Bay, Florida
  140. Shah GK – Presenter: Long Island Ophthalmology Society General Membership Meeting ARMD: Everything You Want to Know But Are Too Afraid To Ask December 3, 2012 Long Island, NY
  141. Shah GK Atlantic Coast Retina Club 2012 Wills Eye Institute Contemporary Management of Retinal Detachment October 20, 2012 Philadelphia, PA
  142. Shah GK Kaiser Permanente Retina Update 2012 Update on Vein Occlusions September 26, 2012 Sacramento, CA
  143. Shah GK Midwest Ophthalmologic Symposium Contemporary Management of Retina Detachment Repair September 8, 2012 St. Louis, MO
  144. Shah GK ASRS 30th Annual Meeting Newer Advances in Vitreo-retina Surgeries: Tools and Techniques August 25-29, 2012 Aria Resort, Las Vegas
  145. Shah GK Grand Rounds Retina Mystery July 10, 2012 University of Mississippi – Jackson
  146. Shah GK 1st Annual OIC WAVE Meeting Discussion Panel – Retinal Detachment June 23-26, Vail, CO
  147. Shah GK Macula Society Triamcinolone-Assisted Internal Limiting Membrane Peeling During Primary Rhmatogenous Retinal Detachment Repair Reduces Postoperative Macular Pucker Formation Vitrectomy Surgery June 11 – 15 – Jerusalem, Israel
  148. Shah GK East Bay Eye Society Vitreoretinal Interface: The Final Frontier May 14, 2012, Berkeley, CA
  149. Shah GK Kresge Eye Institute April 25, 2012, Detroit, MI
  150. Shah GK 26th Annual Mid-Winter Sarasota Vitreoretinal Update Course Retinal Detachment Repair: What are we doing now? ILM Peeling: Indications, Techniques and Outcomes. Retina Vein Occlusions: Current Treatment Options. DRCR Net: What has it shown us? February 17, 2012, Sarasota, FL
  151. Shah GK Minnesota Medical Association Bloomington, MN January 28, 2012 Retinal Detachment Repair: Technique, Outcomes and Economics
  152. Shah GK LuEsther T. Mertz Retinal Research Center. Manhattan Eye, Ear and Throat Hospital – Macula 2012 January 20 and 21, 2012, New York, NY Decision Point Roundtable: Mistakes in VR Surgery and How They Are Managed
  153. Shah GK USC Resident/Fellowship Fluorescein Conference Changing Paradigm: Macular Edema and Retinal Vascular Disease
  154. Shah GK Sacramento Ophthalmological Society Sacramento, CA October 13, 2011 Current Management of Macular Edema: Pathophysiology, Treatment and Outcome
  155. Shah GK 31rst Annual Ophthalmic Conference, Ohio Health. Columbus, OH September 30, 2011. Contemporary Management of Retinal Detachment Repair; Retinal Vein Occlusions: A Primer; Diabetic Retinopathy: Paradigm Shift in Diagnosis and Treatment
  156. Shah GK ASRS 29th Annual Meeting – Boston, MA August 20, 2011- Contemporary Management of Retinal Detachment Repair: Techniques, Outcomes and Case Studies
  157. Shah GK Leuven Retina Meeting –Belgium July 1-3, 2011 Vitrectomy With or Without ILM Peeling 6th Annual Ocular Imaging Conference in Conjunction with AAO 2010, Chicago, IL October 2010. Co-Chair and Presenter.
  158. AAO Annual Meeting. Management of Anti-VEGF Failures: Recognition and Management. Breakfast with the Experts. Roundtable #B637. October 18, 2010.
  159. ASRS Annual Meeting. Vancouver, BC Canada August 28 – September 1, 2010- Contemporary Management of Retina Detachment. A Survey of the Current Status of Vitreoretinal Fellowship Training in the United States and Canada. Ranibizumab vs. PDT for Presumed Ocular Histoplasmosis, Co-Presenter; Complications of Retinal Detachment Surgery Using Scleral Buckles
  160. 2010 S.E. Eye Physicians Destin, FL, July 22-24, 2010. Alternative Therapies for ARMD: Beyond Anti-VEGF Therapy; Advances in Ocular Imaging; ILM Peeling: Indications, Techniques and Outcomes
  161. West Virginia Academy of Ophthalmology 2010 Annual Meeting Roanoke, WV, June 25-27, 2010; Advances in the Diagnosis & Management of Macular Edema; ARMD : Past, Present & Future; Treatment of Retinal Detachments : Should I know How to Buckle and Why
  162. 30th Annual Alamo City Ophthalmology Clinical Conference; San Antonio, TX, March 5-6, 2010; ARMD: Past, Present and Future
  163. Guest Speaker – Nashville Ophthalmological Society; Management of Macular Edema Nashville, TN, January 25, 2010.
  164. 8th Annual International Symposium on Ocular Pharmacology and Therapeutics. Rome, Italy, December 3-6, 2009. Failure of Anti-VEGF Therapy – Recognition and Management with ICGA.
  165. 2nd Advanced Vitreo Retinal Techniques and Technology (AVRTT), Ahmedabad, India, December 19-20, 2009. Update on ARMD Therapy; 23 Gauge Surgery: Expanding Indications and Limitations Including Wound Construction; Spectral Domain OCT: Present Status; Multifocal IOLs Related Visualization Problems for Retinal Surgeons While Doing; Pucker/ILM Peel Procedures; Failed Buckles vs. Vitrectomy
  166. 5th Annual Ocular Imaging Conference in Conjunction with AAO 2009, San Francisco, CA. October 25, 2009. Co-Chair and Presenter.
  167. AAO Annual Meeting. Management of Failed Retinal Detachments: How to Optimize First Operation Success. Breakfast with the Experts. Roundtable #B345. October 2009.
  168. AAO Annual Meeting. 25 and 23 Gauge Instrumentation for Vitrectomy. Round Table Discussion. Roundtable #76. October 2009.
  169. Visiting Professor – Long Island Jewish Medical Center- Management of Anti-VEGF Failures Long Island, NY, September 29, 2009.
  170. Twenty-Third Sarasota Vitreo-Retinal Update Course; Conventional OCT vs High-Speed (Spectral Domain) OCT: Which One do I Need? Advances in Vitreo-Retinal Surgery; Combination Therapy in AMD; Diabetic Macular Edema – Past, Present & Future Sarasota, Florida, February 2009.
  171. AAO Annual Meeting. Exudative AMD: The Treatment Permutations. Breakfast With the Experts. Roundtable #B326. November 2008.
  172. St. Louis Ophthalmological Society. Diabetic Macular Edema and its Current Treatment Paradigm. September 9, 2008.
  173. MOAC Conference. Update on ARMD. August 2, 2008, Lake Louise, Canada.
  174. Grand Rounds, Yale University Eye Center. Advances in Vitreoretinal Surgery. July 15, 2008.
  175. Vitreous Society, 2008. Macular Hole Closure Rates Using Triamcinolone. July, 2008 Frankfurt Retina Meeting 2008. Triamcinolone-Assisted Vitrectomy: Principles, Techniques and Complications. Frankfurt, Germany, April 20, 2008.
  176. Frankfurt Retina Meeting 2008. Macular Hole Surgery: Is There Anything New? Frankfurt, Germany, April 20, 2008.
  177. Ophthalmology Grand Rounds. Macular Edema, Past, Present and Future. University of Cincinnati. March 12, 2008.
  178. Cincinnati Ophthalmological Society. Advances in Management of Surgical Diseases. March 12, 2008.
  179. Visiting Professor 2007. Washington University and the Barnes Retina Institute. Spectral Domain OCT. St. Louis, MO. October 12, 2007.
  180. Ophthalmology Grand Rounds. Retina 2007: What’s New in Retina. Rocky Mountain Lions Eye Institute, Aurora, Colorado. February 2, 2007.
  181. New Jersey Academy of Ophthalmology Meeting. Combination Therapy: What, When and Why. January 2007.
  182. Ophthalmic Update 2007 for Nurses & Technicians. Evolution and Revolution of Retinal Diseases. St. Louis, MO. January 27, 2007.
  183. Des Moines Ophthalmological Society Meeting: Retinal Update 2007 - Into the New Millennium. January 11, 2007
  184. 34th Annual Continuing Education Program: JCAHPO Subspecialty Retina Session: Advances in Surgical Instrumentation, Illumination & Adjuncts; Speaker and Chairman. Las Vegas, NV. November 13, 2006.
  185. 34th Annual Continuing Education Program for JCAHPO: Macular Edema: Past, Present & Future. November 12, 2006.
  186. 2nd Annual Ocular Imaging Conference in Conjunction with AAO 2006, Las Vegas, NV. November 12, 2006. Co-Chair and Presenter.
  187. VACT Visudyne Anti-VEGF Combination, Therapy Data Collection. Las Vegas, NV. November 12, 2006. Guest Speaker.
  188. Strategies for Optimizing Outcomes of AMD. Las Vegas, NV. November 10, 2006. Guest Speaker.
  189. Vitreoretinal Symposium at Whistling Straits: Update on Fungal Endophthalmitis. Kohler, WI. September 16, 2006.
  190. Vitreoretinal Symposium at Whistling Straits: Combination Therapy of PDT and Bevacizumab in ARMD. Kohler, WI. September 16, 2006.
  191. Vitreoretinal Symposium at Whistling Straits: Intraoperative Uses of Triamcinolone. Kohler, WI. September 16, 2006.
  192. Introducing a New Option for the Treatment of Neovascular Age-Related Macular Degeneration (AMD): LUCENTIS (Ranibizumab injection) for Intravitreal Use. Evansville, IN. September 14, 2006 Pro-Drug Therapeutics in Ophthalmic Surgery. Mt. Vernon, IL. June 15, 2006.
  193. Missouri Regional Education Program for Ophthalmic Allied Health Personnel: Revolution and Evolution of Treatment of Retinal Diseases. St. Louis, MO. May 20, 2006.
  194. 20th Annual Association of Technical Personnel In Ophthalmology (ATPO) Annual Scientific Session: Intraocular Steroids and Drug Delivery Systems: Current Concepts and Controversies. Chicago, IL. October 18, 2005.
  195. JCAHPO 33rd Annual Continuing Education Program: Retina/Vitreous Sub-Specialty Session (Course10MO567) – Macular Edema: Past, Present & Future. Chicago, IL. October 17, 2005.
  196. 1st Annual Ocular Imaging Conference in Conjunction with AAO 2005, Chicago, IL October 16, 2005. Co-Chair and Presenter.
  197. Retina 2005: Changing Concepts and Controversies: Kenalog Used as an Adjunct to Identify Vitreous and Internal Limiting Lamina for Vitreous Surgery: AAO 2005 Subspecialty Day, October 14, 2005.
  198. Missouri Regional Education Program for JCAHPO: Macular Edema: Past, Present & Future. Tan-Tar-A Resort, Osage Beach, Missouri. June 4, 2005.
  199. Alcon Roundtable Discussion: Clinical Update. Mount Vernon, Illinois. March 24, 2005.
  200. St. Luke’s Hospital Ophthalmology Conference, ARMD: What, When & Why? St. Louis, MO. March 15, 2005.
  201. Alcon Roundtable discussion: Determination of Vitreous and Aqueous Concentration of Topically Administered Moxifloxacin 0.5% in Humans, St. Louis, MO, April 12, 2004.
  202. St. Luke’s Hospital Ophthalmology Conference, Intravitreal Kenalog: Concepts and Controversies, March 16, 2004.
  203. Shah GK. Role of OCT in Macular Surgery and subsequent panel discussion. 6th International Advanced Vitreo Retinal Surgery Course, Chennai, India. July 24, 2003.
  204. Shah GK. Role of OCT / FFA in diabetic macular edema and subsequent panel discussion. 6th International Advanced Vitreo Retinal Surgery Course, Chennai, India. July 25, 2003.
  205. Shah GK. Role of OCT / FFA in diabetic macular edema and subsequent panel discussion. 6th International Advanced Vitreo Retinal Surgery Course, Chennai, India. July 25, 2003.
  206. Shah GK. Co-Chairman of Session III and subsequent panel discussion. 6th International Advanced Vitreo Retinal Surgery Course, Chennai, India. July 25, 2003.
  207. St. Louis Optometric Society, Update on Photodynamic Therapy. Aug. 12, 2003.
  208. St. Luke’s Hospital Ophthalmology Conference, Surgical Treatment of Retinal Vascular Disease, January 15, 2002.
  209. Central Illinois Optometric Association, Update on Photodynamic Therapy and Retinal Vascular Diseases. April 18, 2001.
  210. Ahmedabad Ophthalmology Society. Age-Related Macular Degeneration and Use of Photodynamic Therapy. November 24, 2000.
  211. Bombay Ophthalmology Society. Management of CRVO and BRVOs; Photodynamic Therapy; AIDS and the Eye. November 13, 2000.
  212. University of Wisconsin Visiting Professor. CMV Retinitis: Diagnosis and Management. January 13, 1999.
Major Conferences and Course Presentations
  1. Shah GK-Speaker, Latest advances in vitreo-retinal surgery. 26th Annual Meeting of VSRI December 1, 2017
  2. Shah GK – Presenter. Management of Combined Schisis Retinal Detachment AAO Annual Meeting. November 10, 2017 New Orleans, LA
  3. Shah GK, Griggs P., Altaweel, M 5th Annual OIC WAVE Conference June 22-25, 2016 – Four Seasons Vail, Colorado
  4. Shah GK, Griggs P., Altaweel M. June 25-28, 2015 - Fairmont Kea Lami, Maui Hawaii
  5. Shah GK, Griggs P., Altaweel, M 3rd Annual OIC WAVE Conference. June 25 – 28, 2014 – Four Seasons Vail, Colorado
  6. Shah GK, Griggs P., Altaweel M. 2nd Annual OIC WAVE Conference June 30 – July 3, 2013 - Fairmont Kea Lami, Maui Hawaii
  7. Shah GK, Spaide R, Warren K, Heier J, Lane R, Blinder K, Tewari A, Ferrone P, Tornambe P.23-Gauge Vitrectomy: What, When and How? - Course AAO Annual Meeting November 12, 2012 – Chicago, IL
  8. Shah GK, Spaide R, Warren K, Heier J, Lane R, Blinder K, Tewari A, Ferrone P, Tornambe P.23-Gauge Vitrectomy: What, When and How? - Lab AAO Annual Meeting November 12, 2012 – Chicago, IL
  9. Shah GK 8th Annual OIC AAO Meeting November 11, 2012 Chicago, IL
  10. Shah GK Retina 2012: The Winds of Change – Presenter Recurrent Retinal Detachment: Does Initial Treatment Matter? AAO Annual Meeting. November 09, 2012 Chicago, IL
  11. Shah GK 31st Annual Squaw Valley Retinal Symposium Olympic Valley, CA February 9-12, 2012; Current Trends in Retinal Detachment Repair; ThromboGenics and Macular Hole Treatment; Treatment of Retinal Vascular Disease with Anti-VEGFs and Steroids; ILM Peeling in 2012; DRCR.net Overview
  12. Shah GK 23rd Annual Ophthalmology Fall Update 2011 St. Louis, MO September 16-17, 2011. Retinal Vein Occlusions: What’s New?
  13. Shah GK Atlantic Coast Conference/Wills Eye Retina Anniversary Philadelphia, PA. January 29, 2011. Are Scleral Buckles Obsolete?
  14. Shah GK 19th Annual Conference of Vitreo Retinal Society – Mysore, India. December 2 – 4, 2010. Update on Management of Retinal Detachment; Macular Edema: concepts and controversies
  15. Shah GK, Spaide RF, Tornambe PE, Warren KA, Heier JS, Lane RG, Blinder KJ, Ferrone PJ, Tewari A, Pollack JS. 23-Gauge Vitrectomy Surgery: Principles and Technique. AAO Annual Meeting. October 2010. Lecture #549.
  16. Shah GK, Spaide RF, Tornambe PE, Warren KA, Park, RI, Heier JS, Lane RG, Blinder KJ, Ferrone PJ, Toth CA. 23-Gauge Vitrectomy Surgery: Principles and Technique. AAO Annual Meeting. October 2009. Lecture #190.
  17. Shah GK, Blinder KJ, Mittra RA, Eliott D, Tewari A. Internal Limiting Membrane Peeling: Everything You Wanted to Know but Were Afraid to Ask. AAO Annual Meeting. October 2009. Course #698.
  18. Shah GK. Recognition and Management of Anti-VEGF Non-Responders. AAO Annual Meeting Subspecialty Day. October 2009.
  19. Shah GK, Spaide RF, Tornambe PE, Warren KA, Park, Retina Institute, Shaikh SA, Heier JS, Lane RG, Blinder KJ, Tewari A. 23-Gauge Vitrectomy Surgery: Principles and Technique. AAO Annual Meeting. November 2008. Lecture #173.
  20. Shah GK, Blinder KJ, Mittra RA, Eliott D, Tewari A. Internal Limiting Membrane Peeling: Everything You Wanted to Know but Were Afraid to Ask. AAO Annual Meeting. November 2008. Course #369.
  21. Shah GK, Spaide RF, Tornambe PE, Warren KA, Park RI, Saikh SA, Heier JS, Toth CA, Blinder KJ, Lane G, Tewari A. 23-Gauge Vitrectomy Surgery: Principles and Technique. AAO Annual Meeting. November 2007. Course #482.
  22. Ocular Imaging Conference. AAO Annual Meeting. November 2007.
  23. Scientific Session on Age-Related Macular Degeneration. XVI Annual Conference of Vitreo-retinal Society of India. September 22, 2007.
  24. Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration. Masters of the ASRS 3rd Annual Meeting. Montego Bay, Jamaica. February 21-27, 2007.
  25. 23-Gauge Transconjunctival Sutureless Vitrectomy. Masters of the ASRS 3rd Annual Meeting. Montego Bay, Jamaica. February 21-27, 2007.
  26. Shah GK, Blinder KJ, Altaweel MM, Banker AS. Intravitreal Agents: Pearls and Pitfalls. AAO Annual Meeting. November 2006. Course #693.
  27. Shah GK, Blinder KJ, Engelbrecht NE, Thomas MA. Contemporary Management of Exudative AMD: What, When & Why. AAO Annual Meeting. November 2006. Course #494.
  28. Shah GK, Spaide RF, Tornambe PE,. Warren KA, Park RI, Shaikh SA, Heier JD, Toth CA. 23 Gauge Vitrectomy Surgery: Principles and Techniques. AAO Annual Meeting. November 2006. Course #305 and Lab 305A. 18th Annual Ophthalmology Fall Update: Advances in Vitreoretinal Surgery. St. Louis, MO. September 15, 2006.
  29. Shah GK. Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration. 24th Annual ASRS Meeting, Cannes, France. September 2006.
  30. Altaweel MM, Olsen TW, Gottlieb JL, Ip MS, Shah GK. Postoperative and Post-Intravitreal Injection Endophthalmitis: Prevention, Evaluation and Management. AAO Annual Meeting. October 2005. Course #414.
  31. Shah GK, Blinder KJ, Engelbrecht NE, Thomas MA. Contemporary Management of Exudative Age-Related Macular Degeneration: What, When and Why. AAO Annual Meeting. October 2005. Course #271.
  32. Shah GK, Blinder KJ, Altaweel MM, Holekamp NH, Banker AS, Intravitreal Kenalog: Pearls and Pitfalls. AAO Annual Meeting. October 2005. Course #233.
  33. 17th Annual Ophthalmology Fall Update: Surgical Advances in Vitreoretinal Surgery. St. Louis, MO. September 23, 2005.
  34. Midwinter Course 2005: Macular Edema – Past, Present & Future. St. Louis, MO. February 12, 2005. Shah GK, Blinder KJ, Altaweel MM, Holekamp NH. Intravitreal Kenalog: Pearls and Pitfalls. AAO Annual Meeting. October 2004. Course #599.
  35. Altaweel, MM, Flynn HW, Gottlieb JL, Ip MS, Shah GK. Postoperative Endophthalmitis: Evaluation and Management and accompanying lab. AAO Annual Meeting. October 2004. Course #568 presentation.
  36. Altaweel, MM, Flynn HW, Gottlieb JL, Ip MS, Shah GK. Postoperative Endophthalmitis: Evaluation and Management and accompanying lab. AAO Annual Meeting. November 2003. Course #568 presentation.
  37. Blinder, KJ, Boniuk I, Burgess DB, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Rao PK, Shah GK, Thomas MA: Macular Surgery: Indications, Techniques, and Complications. AAO Annual Meeting November 2003. Course 519 presentation.
  38. Altaweel, MM, Olsen TW, Shah GK, Gottlieb JL, Das T, Ip MS. Postoperative Endophthalmitis: Evaluation and Management and accompanying lab. AAO Annual Meeting. October 2002. Course #137 and Lab #HO-256 presentations.
  39. Blinder, KJ, Boniuk I, Burgess DB, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Rao PK, Shah GK, Thomas MA: Macular Surgery: Indications, Techniques, and Complications. AAO Annual Meeting October 2002. Course 344 presentation.
  40. 14th Annual Ophthalmology Fall Update, Washington University; Fluocinolone Implant. September 2002
  41. Course Director - Mid-Winter Course 2002, St. Louis, MO. Surgical Treatment of Retinal Vascular Disease
  42. Blinder KJ, Boniuk I, Burgess DB, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Rao PK, Shah GK, Thomas MA: Macular Surgery: Indications, Techniques, and Complications. AAO Annual Meeting November 2001. Course 525
  43. Mid-Winter Course 2000, St. Louis, MO. Update of Branch and Retinal Vein Occlusion. Retina Board Review for Residents and Fellows, 2000 – present
  44. St. Louis Optometric Association. Management of BRVO and CRVO. September 2000
  45. Washington University School of Medicine. Department of Ophthalmology and Visual Sciences Resident Lecture Series 1999 – 2014
  46. Washington University School of Medicine Department of Ophthalmology and Visual Sciences Grand Rounds 1999 – 2014
Clinical Trials
  1. Sub Investigator, OPHTHAOTECH (Age-Related Macular Degeneration. A phase 3 randomized, double masked, controlled trial to establish the safety and efficacy of intravenous administration of Fovista (anti-PDGF-B Pegylated Aptamer) administered in combination with Lucentis compared to Lucentis monotherapy in subjects with subfoveal neovascular Age-Related Macular Degeneration. Approved
  2. Principal Investigator, Ocriplasmin Research to Better Inform Treatment (ORBIT). Approved
  3. Principal Investigator, Ozurdex for Epiretinal Membrane. Approved
  4. Principal Investigator, Ozurdex for Retinal Vein Occlusions. Approved
  5. Sub Investigator, Score 2 (Retinal Vein Occlusion) Study of COmparative Treatments for REtinal Vein Occlusion 2 [SCORE2]: a Multicenter, Prospective, and Randomized Non-inferiority Trial of Eyes with Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 weeks with Intravitreal Aflibercept Every 4 weeks. Approved
  6. Principal Investigator, CRAVE: Comparison of Anti-VEGF agents in the treatment of macular edema from retinal Vein occlusion. IRB Approved.
  7. Principal Investigator, Dexamethasone Intravitreal Implant After Vitrectomy For Idiopathic Epiretinal Membrane.
  8. Principal Investigator, A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema.
  9. Sub Investigator, Phase 1/2a, Multicenter, Randomized, Dose Escalation, Fellow-Eye Controlled Study Evaluating the Safety and Clinical Response of a Single, Subretinal Administration of Human Umbilical Tissue-Derived Stem Cells (CNTO 2476) in Subjects with Visual Acuity Impairment Associated with the Geographic Atrophy Secondary to Age-related Macular Degeneration.
  10. Sub Investigator, An Open Label, Multi-center Extension Study of the Safety and Utility of the New Inserter of ILUVIEN (Fluocinolone Acetonide Intravitreal Insert) 0.19mg and the Safety of ILUVIEN in Subjects with Diabetic Macular Edema. IRB approved.
  11. Principal Investigator, Anatomic Outcomes following Ozurdex Injection using Spectral Domain Optical Coherence Tomography Principal Investigator, CNV Secondary to AMD Treated with Beta Radiation Epiretinal Therapy (CABERNET) sponsored by NeoVista. A Randomized, Prospective, Active Controlled Study of the NeoVista System for the Treatment of Subfoveal Choroidal Neovascularization Associated with Wet Age-Related Macular Degeneration
  12. Principal Investigator, EMERALD Study, a Phase 2, Randomized, Masked, Controlled Clinical Study to Assess the Safety and Efficacy of Lucentis® Plus Sirolimus Versus Lucentis® Plus Placebo in Patients with Sub-Foveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (EMERALD) sponsored by Macusight (pending)
  13. Principal Investigator, OLIVER, an Open-Label, Single-site, Comparative, Pilot Study of the Treatment Effects of Combination Therapy of LucentisTM (Ranibizumab) Plus Reduced Fluence Photodynamic with Visudyne® in Patients with Exudative Age-Related Macular Degeneration (AMD)
  14. Principal Investigator, Spectral OCT, To utilize Time Domain OCT and Spectral OCT Imaging on the same patient population allowing to better understand the effects of LucentisTM monotherapy and combination therapy of LucentisTM and Visudyne®
  15. Principal Investigator, VIEW 1 Study, A Randomized, Double Masked, Active, Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration View 1 (VEGF TRAP-Eye: Investigation of Efficacy and Safety in Wet AMD)
  16. Principal Investigator, Macugen® for Histoplasmosis-An Open-Label, Single-Site, Comparative Prospective Case Series
  17. Principal Investigator, SCORE (Standard Care vs. Corticosteroid for Retinal Vein Occlusion) Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide with Standard Care to Treat Macular Edema: One for Central Retinal Vein Occlusion and One for Branch Retinal Vein Occlusion
  18. Sub-Investigator, ACTU (Aids Clinical Trials Unit) Studies, Washington University School of Medicine; multiple studies
  19. Sub-Investigator, Alcon C-02-60 AART – An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study “A” or Study “B”) at Risk for Developing Sight-Threatening Choroidal Neovascularization (CNV) Due to Exudative Age-Related Macular Degeneration (AMD)
  20. Sub-Investigator, Allergan 206207-008 – A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with six-month open-label extension) to Assess the Safety and Efficacy of 700 µg and 330 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Macular Edema Following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion
  21. Sub-Investigator, Anecortave Acetate in Age-Related Macular Degeneration, The Alcon Studies, C-98-03 and C-00-07
  22. Sub-Investigator, A Multi-Center, Randomized, Double-masked, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide (0.5 or 2 mg) Implant in Patients with Non Infectious Uveitis Affecting the Posterior Segment of the Eye, Bausch & Lomb, Inc.
  23. Sub-Investigator, Complications of Age-related Macular Degeneration Prevention Trial; The CAPT Study
  24. Sub-Investigator, DCCT Ophthalmologist, Diabetes Control and Complications Trial
  25. Sub-Investigator, DRCR (Evaluation of Vitrectomy for Diabetic Macular Edema Study)
  26. Sub-Investigator, DRCR IVT (Diabetic Retinopathy Clinical Research Network) A Randomized Trial Comparing Intravitreal Corticosteroids and Laser Photocoagulation for Diabetic Macular Edema, Protocol B
  27. Sub-Investigator, DRCR Laser (A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema, Version 1.2
  28. Sub-Investigator, Eyetech 1012 – A Phase 3B/4, Randomized, active-controlled, double-masked, single dummy, multi-center comparative trial, in parallel groups, to compare the safety and efficacy of intravitreous injections of Macugen given every six weeks for up to 102 weeks, plus sham photodynamic therapy (PDT), to Macugen plus PDT with Visudyne in subjects with predominantly classic subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration.
  29. Sub-Investigator, FIHNESSE – A Phase One/Two, Randomized, Masked, Placebo-Controlled, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety and Efficacy of AG-013958 in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration
  30. Sub-Investigator, FOCUS – A Phase I/II, Single-Masked, Multicenter Study of the Safety, Tolerability and Efficacy of Multiple-Dose Intravitreal Injections of rhuFab V2 in combination with Verteporfin (Visudyne™) Photodynamic Therapy in Subjects with Neovascular Age-Related Macular Degeneration
  31. Sub-Investigator, MARINA – A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) in Subjects with Minimally Classic or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
  32. Sub-Investigator, MUST – Multicenter Uveitis Steroid Treatment Trial.
  33. Sub-Investigator, Pfizer A4321001, A Phase 1/2 Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety and Efficacy of AG-013958 in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration.
  34. Sub-Investigator, Regeneron, An Exploratory Study of the Safety, Tolerability and Biological Activity of Intravenously Administered VEGF Trap in Patients with Diabetic Macular Edema.
  35. Sub-Investigator, SAILOR – A Phase IIIb, Single-Masked, Multicenter, Randomized Study to Evaluate the Safety and Tolerability of Ranibizumab in Naïve and Previously Treated Subjects with Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  36. Sub-Investigator, Sandostatin LAR in Diabetic Retinopathy, The Novartis Study
  37. Sub-Investigator, VER (Visudyne Early Retreatment) Multicenter, Randomized, Parallel group, Double-Masked, Controlled Phase IIIb, 2-year Study comparing the Efficacy and Safety of Visudyne Therapy with Early Retreatment to Standard Retreatment in Predominantly Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  38. Sub-Investigator, VERITAS – A 24 month randomized, double-masked, sham controlled, multicenter, Phase IIIB study comparing photodynamic therapy with verteporfin (Visudyne) plus two different dose regimens of intravitreal triamcinolone acetonide (1mg and 4 mg) versus Visudyne plus intravitreal pegaptanib (Macugen) in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
  39. Sub-Investigator, Validation of the Visual Function Questionnaire-25 (VFQ-25) in People with Age-Related Macular Degeneration
  40. Sub-Investigator, VIO (Visudyne Therapy in Occult) A Randomized, Placebo-Controlled, Double-Masked, Multicenter Phase III Study of the Effect of Visudyne Therapy in Occult with No Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  41. Sub-Investigator, Vitrase Study: Safety and Efficacy Study of Vitrase for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage
  42. Sub-Investigator, A Randomized, Double-Masked, Parallel Group, Multicenter, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 μg/day and ASI-001B 0.2 μg/day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects with Diabetic Macular Edema
  43. Sub-Investigator, Age-Related Eye Disease Study 2 (AREDS2): A Multicenter, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA] in Age-Related Macular Degeneration
  44. Sub-Investigator, Lucentis for Histo, Ranibizumab vitreous syneresis PDT for Presumed Ocular Histoplasmosis
  45. Sub-Investigator, BRAVO, A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared with Sham in Subjects with Macular Edema Secondary to Branch Retinal Vein Occlusion
  46. Sub-Investigator, CRUISE, A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared with Sham in Subjects with Macular Edema Secondary to Central Retinal Vein Occlusion
  47. Sub-Investigator, FAME, A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 µg/day and ASI-001B 0.2 µg/day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects with Diabetic Macular Edema
  48. Sub-Investigator, Denali, A 24-month, Randomized, Double-Masked, Controlled, Multicenter, Phase IIIB Study Assessing Safety and Efficacy of Verteporfin (Visudyne®) Photodynamic Therapy Administered in Conjunction with Ranibizumab (LucentisTM) Versus Ranibizumab (LucentisTM) Monotherapy in Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration